| (+)-4-Amino-3-isoxazolidinone, (+)-6-[Amino(4-chlorophenyl)(1-methyl-1H-imidazol-5-yl)methyl]-4-(3-chlorophenyl)-1-methyl-2(1H)-quinolinone, (+)-A 127722, (+)-Aldosterone, (+)-alpha-Tocopherol, (+)-alpha-Tocopherol Acetate, (+-)-2-Amino-N-(beta-hydroxy-2,5-dimethoxyphenethyl)acetamide Monohydrochloride, (+-)-alpha-((tert-Butylamino)methyl)-3,5-dihydroxybenzyl Alcohol Sulfate(2:1)(salt), (+/-)-alpha-Tocopherol, (-)-alpha-(1-Aminoethyl)-3,4-dihydroxybenzyl Alcohol, (--)-2Amino-3-)3,4-dihydroxyphenyl)propanoic Acid, (1 Alpha,11 alpha)-11-(acetyloxy)-1-(methoxymethyl)-2-oxaandrosta-5,8-dieno(6,5,4-bc)furan- 3,7,17-trione, (11alpha,13E)-(+-)-11,16-Dihydroxy-16-methyl-9-oxo-prost-13-en-1-oic Acid Methyl Ester, (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic Acid, (17-alpha)-13-Ethyl-17-hydroxy-11-methylene-18,19-dinorpregn-4-en-20-yn-3-one, (17Alpha)-13-ethyl-17-hydroxy-18,19-dinorpregn-4-en-20-yn-3-one, (17alpha)-19-Norpregna-1,3,5(10)-trien-20-yne-3,17-diol, (17alpha)-3-Methoxy-19-norpregna-1,3,5(10)-trien-20-yn-17-ol, (17alpha)-Pregna-2,4-dien-20-yno[2,3-d]isoxazol-17-ol, (1alpha,2alpha,3beta,4alpha,5alpha,6beta)1,2,3,4,5,6-Hexachlorocyclohexane, (1alpha,3beta,5Z,7E)-9,10-Secocholesta-3,7,10(19),16-tetraene-1,3,25-triol, (1alpha,3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-triene-1,3,25-triol, (1alpha,3beta,5Z,7E)-9,10-Secostigmasta-5,7,10(19)-triene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1aR,2Z,4E,14R,15aR)-8-Chloro-1a,14,15,15a-Tetrahydro-9,11-dihydroxy-14-methyl-6H-oxireno[e][2]benzoxacyclotetradecin-6,12(7H)-dione, (1aS,8S,8aR,8bS)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione, (2alpha,3beta)-2,3,23-Trihydroxyurs-12-en-28-oic acid, O-6-deoxy-alpha-L-mannopyranosyl-(1--4)--beta-D-glucopyranosyl-(1--6)-O-beta-D-glucopyranosyl Ester, (3alpha,5beta,7beta)-3,7-Dihydroxycholan-24-oic acid, (4-Amino-1-hydroxybutylidene)bisphosphonic Acid, (4Alpha,5alpha,17beta)-4,5-epoxy-3,17-dihydroxyandrost-2-ene-2-carbonitrile, (5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one Hydrochloride, (5alpha,17beta)-17-Hydroxyandrostan-3-one, (5alpha,17beta)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, (5alpha,6alpha)-17-(Cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol Hydrochloride, (6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione, (6Alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione, (6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione, (6alpha,11beta,16alpha)-21-(Acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione, (6alpha,11beta,16alpha)-6,9-Difluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]pregna-1,4-diene-3,20-dione, (6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester, (7alpha,11beta,16alpha)-7-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione, (7aS-cis)-13,13a-Dihydro-9,10-dimethoxy-3,3-dimethyl-3H-bis[1]benzopyrano[3,4-b:6',5'-e]pyran-7(7aH)-one, (9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, (aa Beta, 17 beta)-11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one, (All-E)-3,7-Dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic Acid, (All-E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid, (all-Z)-5,8,11,14-Eicosatetraenoic Acid, (Aorto)coronary bypass of four or more coronary arteries, (Aorto)coronary bypass of one coronary artery, (Aorto)coronary bypass of three coronary arteries, (Aorto)coronary bypass of two coronary arteries, (asterisk) Life of the "unit." Used for blood products., *Activity, *Arbitrary, .alpha.-Linolenic acid, 1 aminocyclopentyl 1,3 dicarboxylate, 1,1a,2,2,3,3a,4,5,5,5a,5b,6-Dodecachloro-octahydro-1,3,4-metheno-1H-cyclbuta[cd]pentalene, 1,2,3,4,4a,4b,7,9,10,10a-Decahydro-2-hydroxy-2,4b-dimethyl-7-oxo-1-phenanthrenepropionic Acid Delta-Lactone, 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine, 1-(alpha-methoxymethyl ethanol)-2-Nitroimidazole, 1-(aminomethyl)cyclohexaneacetic Acid, 1-ABaP, 1-Acetamido-4-ethoxybenzene, 1-Acetyl-2-picolinoylhydrazine, 1-Allyl-3,4-methylenedioxybenzene, 1-Amino-2,4-dibromo-9,10-anthracenedione, 1-Amino-2-methyl-9,10-anthracenedione, 1-amino-3,5-dimethyladamantane Hydrochloride, 1-Amino-6,17-dihydroxy-7,10,18,21-tetraoxo-27-(n-acetylhydroxylamino)-6,11,17,22-tetraazaheptaeicosane, 1-Aminocyclopentane, 10a, 11a, 12-Allyldeoxoartemisinin, 12a, 13a, 14a, 15a, 16-(3-Amino-3,6-didesoxy-beta-D-mannopyranosyloxy)-5,6-epoxy-8,12,14-trihydroxy-26-methyl-2,10-dioxo-1-oxacyclohexacosa-3,17,19,21,23-pentaen-13-carbonsaeure, 16a, 16alpha-Fluoroandrost-5-en-17-one, 17 Alpha-methyl-delta4-androsten-17beta-ol-4-one, 17-(Acetyloxy)-6-chloropregna-4,6-diene-3,20-dione, 17-(Allylamino)-17-demethoxygeldanamycin, 17a, 17ad, 17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione, 17am, 18a, 18ad, 18am, 19a, 19ad, 19am, 1a, 1alphaH,5alphaH-Tropan-3alpha-ol, 6beta,7beta-epoxy-,(-)-tropate(ester), 1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide,(-)-tropate(8CI), 2 Alpha-Methyldihydrotestosterone Propionate, 2 amino 4 phosphonobutyrate, 2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium Chloride, 2-(1-(Ammoniocarbonyl)-3-(diisopropylammonio)-1-phenylpropyl)pyridinium Phosphate, 2-(2-Amino-3-methoxyphenyl)-4H-1-benzopyran-4-one, 2-(Acetyloxy)benzoic Acid, 2-AAF, 2-Acetoxyethyltrimethylammonium Chloride, 2-Amino 6MP, 2-Amino, 6-Methoxypurine Arabinoside, 2-Amino-1,3-Dihydroxyoctadecane, 2-Amino-1,7-dihydro-6H-purin-6-one, 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one, 2-Amino-1,9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6H-purin-6-one, 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine, 2-Amino-3,4-Dimethylimidazole[4,5-f]quinoline, 2-Amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-Amino-3-(5-hydroxy-1-H-indol-3-yl)propionic Acid, 2-Amino-3-hydroxypropionic Acid, 2-Amino-3-methylimidazo[4,5-f]quinoline, 2-Amino-4-(S-butylsulfonimidoyl) Butanoic Acid, 2-Amino-5-(carbamoylamino)pentanoic Acid, 2-amino-5-bromo-6-phenyl-4-(3H)-pyrimidinone, 2-Amino-5-chlorotoluene, 2-Amino-6-(trifluoromethoxy)benzothiazole, 2-Amino-9,10-anthracenedione, 2-Aminonaphthalene, 2-Aminotoluene, 2-Aza-8-germaspiro[4.5]decane-2-propanamine, 8, 8-diethyl-N,N-dimethyl-, dihydrochloride, 2-Aziridinecarboxamide, 1-[1-(2-cyano-1-aziridinyl)-1-methylethyl], 2-[(Aminocarbonyl)oxy]-N,N,N-trimethyl-1-propanaminium Chloride, 20a, 21-(Acetyloxy)-17-hydroxypregn-4-ene-3,11,20-trione, 21a, 22a, 23a, 24a, 25a, 26a, 27a, 28a, 29a, 2a, 2alpha,3beta,23-Trihydroxyurs-12-en-28-oic Acid, 2alpha,3beta,6beta,23-Tetrahydroxyurs-12-en-28-oic Acid, 3'-Azido-3'-deoxythymidine, 3,3'-Azobis[6-hydroxybenzoic Acid], 3-((4-Amino-2-methyl-5-pyrimidinyl)methyl)-5-(2-hydroxyethyl)-4-m-ethylthiazolium Chloride, Monohydrochloride, 3-(5,10,11,11a-tetrahydro-9,11-dihydroxy-8-methyl-5-oxo-1h-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-2-propenamide, 3-(Aminocarbonyl)-O4-deacetyl-3-de-(methoxycarbonyl)vincaleukoblastine, 3-(Aminomethyl)-5-methyl-hexanoic Acid, 3-ABaP, 3-Amino-1,2,4-benzotriazine-1,4-dioxide, 3-Amino-1-[4-(2 amino-1H-imidazolyl]-propanol, 2HCl, 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone, 3-AP/Cisplatin/Paclitaxel, 3.Alpha,4.Beta, 15-triol, 12, 13-epoxy-,4, 15-diacetate (8CI), 30a, 30ad, 30am, 31a, 31ad, 31am, 32a, 32ad, 32am, 3a, 3AP/FAMP, 4 aminosalicylic acid, 4'-(9-Acridinylamino)methane-sulfon-m-anisidide, 4'-Amino-6-hydroxyflavone, 4,5-alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one Hydrochloride, 4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride, 4-(Acetylamino)-N-(2-aminophenyl)benzamide, 4-(all-trans-retino-yl)aminophenol, 4-(Aminomethyl)benzenesulfonamide Monoacetate, 4-Acridinecarboxamide,9-((2-methoxy-4-((methylsulfonyl)amino)phenyl)amino-N,5-dimethyl, 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one, 4-Amino-10-methylfolic Acid, 4-Amino-2(1H)-pyrimidinone, 4-Amino-2-(ethoxymethyl)-alpha,alpha-dimethyl-1H-imidazo[4,5-c]quinoline-1-ethanol, 4-Amino-3-(4-chlorophenyl)-butanoic Acid, 4-Amino-3-[[4'-((2,4-Diaminophenyl)azo)(1,1'-Biphenyl)-4-yl]azo]-5-Hydroxy-6-(Phenylazo)- 2,7-Naphthalenedisulfonic Acid, Disodium Salt, 4-Amino-5-fluoro-2(1H)-pyrimidinone, 4-Amino-7.beta.-D-ribofuranosyl-7H-pyrrolo(2, 3-d)pyrimidine, 4-Amino-N-(3,4-dimethyl-5-isoxazolyl)benzenesulfonamide, 4-Aminobenzenesulfonamide, 4-Aminofolic acid, 4-Androstene-3,17-dione, 4a, 5 Alpha-Reductase Inhibitor, 5 aminolevulinate synthase, 5'-[(3-Amino-3-carboxypropyl)methylsulfonio]-5'-deoxyadenosine Hydroxide, Inner Salt, 5-ALA, 5-Amino-2-hydroxybenzoic Acid, 5-Amino-6-(70-amino-5,8-dihydro-6-methoxy-5,8-dioxo-2-quinolyl)-4-(2-hydroxy-3,4-dimethoxyphenyl)-3-methylpicolinic Acid, 5-AZA-dCyd/IDA, 593A, 5a, 5a-Reductase Inhibition, 5alpha,7alpha(S))-alpha-tert-Butyl-17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol Hydrochloride, 5alphaR, 6 aminonicotinamide… (+)-1-Beta-D-arabinofuranosyl-5-[(E)-2-bromovi- ny1] uracil, (+)-Biotin, (-)-Bactobolin, (1,1'-Biphenyl)-2-carboxylic Acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-, (1,1'-Biphenyl)-3-carboxylic Acid, 2',4'-difluoro-4-hydroxy-, (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione, (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, (11beta)-11,21-Dihydroxypregn-4-ene-3,20-dione, (11beta)-21-(3-Carboxy-1-oxopropyl)-11,17-dihydroxypregn-4-ene-3,20-dione, Monosodium Salt, (11beta,16alpha)-21-(3,3-Dimethyl-1-oxobutoxy)-9-fluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))pregna-1,4-diene-3,20-dione, (11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione, (11beta,16alpha)-9-Fluoro-11,16,17,21-tetrahydroxypregna-1,4-diene-3,20-dione, (11Beta,16alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione, (11beta,16alpha,17beta)-11-Hydroxy-16,17-dimethyl-17-(1-oxopropyl)androsta-1,4-dien-3-one, (11beta,16beta)-9-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione, (11beta,16beta)-9-Chloro-11-hydroxy-16-methyl-17,21-bis(1-oxopropoxy)pregna-1,4-diene-3,20-dione Dipropionate, (11Beta,17beta)-9-fluoro-11,17-dihydroxy-17-methylandrost-4-en-3-one, (11beta-21-[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy]-11,17-dihydroxypregna-1,4-diene-3,20-dione, (17beta)-17-(1-Oxopropoxy)androst-4-en-3-one, (17Beta)-17-hydroxy-17-methylandrost-4-en-3-one, (17Beta)-17-hydroxyandrost-4-en-3-one, (17beta)-2-Methoxyestra-1,3,5(10)-triene-3,17-diol, (17beta)-Estra-1,3,5(10)-triene-3,17-diol, (17beta)-Estra-1,3,5(10)-triene-3,17-diol 3-Benzoate, (17beta)-Estra-1,3,5(10)-triene-3,17-diol Dipropanoate, (2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6'7, 7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-, (3-beta)-cholest-5-en-3-ol 4-(bis(2-chloroethyl)amino)benzeneacetate, (3-beta,17-alpha)-19-Norpregn-4-en-20-yne-3,17-diol Diacetate, (3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid, (3beta)-Stigmast-5-en-3-ol, (3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic Acid Methyl Ester, (3beta,20beta)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic Acid, (3beta,20beta)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic Acid, (3beta,20beta)-3-Hydroxy-11-oxoolean-12-en-29-oic Acid, (3beta,5beta)-3-[(O-2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide, (3beta,5Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol, (5-Benzoyl-1H-benzimidazol-2-yl)-carbamic Acid Methyl Ester, (9beta,10alpha)-17-(Acetyloxy)-6-methylpregna-4,6-diene-3,20-dione, (betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid, .beta.,.beta.'-Dichlorodiethylaniline, .beta.,.beta.-Dimethylcysteine, .beta.-2'-Deoxy-6-thioguanosine, .beta.-Carotene, .beta.-Cytosine arabinoside, .beta.-Pyrazomycin, 06-Benzyl Guanine, 1 benzazine, 1, 4-Benzenedicarboximidamide, N, N''-bis[4-[imino(methylamino)methyl]phenyl]-, tetrahydrochloride, 1, 4-Bis[methanesulfonoxy]butane, 1,1'-Bi(ethylene Oxide), 1,1'-Biphenyl-4-amine, 1,14-bis(ethylamino)-5,10-diazatetradecane, 1,2-Benz(a)anthracene, 1,2-Benzenedicarboxylic Acid, Bis(2-ethylhexyl), 1,2-Benzisoxazole-3-methanesulfonamide, 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-(methylaminocarbonyl)hydrazine, 1,3-Benzenediol, 5-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, Sulfate(2:1)(Salt), 1,3-Bis(2,3-epoxypropoxy)benzene, 1,3-Bis(2-chloroethyl)-1-nitrosourea, 1,3-Butadiene, 1,4 benzenediol, 1,4-Benzenediamine, 2,6-Dichloro-N(sup 1)-(4,5-dihydro-1H-imidazol-2-yl), Monohydrochloride, 1,4-Benzenedicarboximidamide, 1,4-bis[[2-[(2-Hydroxyethyl)amino]ethyl]amino]9,10-anthracenedione, 1,5-(butylimino)-1,5-dideoxy-D-glucitol, 1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(di-methylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-(2S-cis)-,(S)-hydoxybutanedioate(1:1), 1-(2-(beta-naphthyloxy)ethyl)-3-methyl-2-pyrazolin-5-one, 1-.beta.-D-Ribofuranosyl-1H-1,2, 4-triazole-3-carboxamide, 1-beta-D-Ribofuranosyl-2(1H)-pyrimidinone, 1-bis(2-chloroethyl)-amino-1-oxo-2-aza-5-oxaphosphoridin monohydrate, 1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]-, 10,11-Benzofluoranthene, 10-19% BDY BRN/10-19% 3D, 10-19% BDY BRN/3 DEG NOS, 11,12-Benzo[k]fluoranthene, 11-beta,17-alpha,21-Trihydroxy-4-pregnene-3,20-dione 17-alpha-butyrate, 11-beta-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione, 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-Acetate, 11beta,17,21-Trihydroxypregn-4-ene-3,20-dione 17-Valerate, 17 Beta-hydroxy-2 alpha-methyl-5 alpha-androstan-3-one, 17 Beta-Hydroxysteroid Dehydrogenase Type 7, 17 Beta-OH-7 beta, 17 alpha-dimethyl-androst-4-ene-3-one, 17-Beta Hydroxysteroid Dehydrogenase, 17beta-(estra-1,3,5(10)-triene-3,17-diol 3-[bis(2-chloroethyl)carbamate], 17Beta-Cyclopentanepropionate, 17beta-Estradiol 17-Cyclopentylpropionate, 17Beta-hydroxyestra-1,3,5(10)-trien-3-yl Acetate, 2 benzazine, 2'-Beta-Fluoro-2',3'-Dideoxyadenosine, 2,1,3-Benzothiadiazol-4-amine, 5-chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-, Monohydrochloride, 2,2'-Biphenylylene Sulfide, 2,2-bis(Bromomethyl)-1,3-Propanediol, 2,3-Benzfluoranthene, 2,6-Bis(1,1-dimethylethyl)-4-methylphenol, 2-(4-Bromophenyl)-4H-1-benzopyran-4-one, 2-.beta.-D-Ribofuranosyl-4-thiazolecarboxamide, 2-Benzimidazolinebutryric acid, 1-methyl-5-bis(2-chloroethyl)amino-, hydrochloride, 2-benzofurancarboximide,N-(2-((1-(chloromethyl)-1,6-dihydro-8-methyl-5-(((phenylamino)carbonyl0oxy0benzo(1,2-b:4,3-b')dipyrrol-3(2H0-yl)carbonyl-1H-indol-5-yl)-6-(diethylamino)-,(S), 2-bis[Cyclo(N-methyl-L-valyl-sarcosyl-L-prolyl-D-valyl-L-threonyl)]-1,9 dimethyl-4,6 3H-phenoxazinone-3, 2-Bromo-alpha-ergocryptine, 2-Bromo-alpha-ergocryptine Mesylate, 2-Butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, sodium salt, (Z)- (9CI), 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt, 2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorine 2-oxide, 2-[bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, 20-29% BDY BRN/10-19% 3D, 20-29% BDY BRN/20-29% 3D, 20-29% BDY BRN/3 DEG NOS, 2B1, 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide, 3,3'-[(1,1'-Biphenyl)-4,4'-Diylbis(Azo)]Bis(5-Amino-4-Hydroxy)- 2,7-Naphthalenedisulfonic Acid, Tetrasodium Salt, 3,4-Benzpyrene, 3,5-Bis(acetylamino)-2,4,6-triiodobenzoic Acid, 3,6-bis-(2-piperidinoethoxyl)acridine trihydrochloride, 30-39% BDY BRN/10-19% 3D, 30-39% BDY BRN/20-29% 3D, 30-39% BDY BRN/3 DEG NOS, 30-39% BDY BRN/30-39% 3D, 3B-O-(4-O-Acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin D, 3beta-Hydroxy-11-oxoolean-12-en-30-oic Acid Hydrogen cis-1,2-cyclohexanedicarboxylate, 3beta-Hydroxyandrost-5-en-17-one, 3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate, 4,4'-Bis(dimethylamino)diphenylmethane, 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride, 4-(3'-bromoanilino)-6,7-dimethoxyquinazoline, 4-[bis(2-chloroethyl)amino]-L-phenylalanine, 40-49% BDY BRN/10-19% 3D, 40-49% BDY BRN/20-29% 3D, 40-49% BDY BRN/3 DEG NOS, 40-49% BDY BRN/30-39% 3D, 40-49% BDY BRN/40-49% 3D, 4B5 monoclonal antibody anti-idiotype vaccine, 5 bromodeoxycytidine, 5 bromodeoxyuridine, 5 bromouracil, 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-Indol-2-one Monohydrochloride, 5-(bis-(2-Chloroethyl) Amino) Uracil, 5-[3, 3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide, 5-[[2-(2-Butoxyethoxy)ethoxy]methyl]-6-propyl-1,3-benzodioxole, 50-59% BDY BRN/10-19% 3D, 50-59% BDY BRN/20-29% 3D, 50-59% BDY BRN/3 DEG NOS, 50-59% BDY BRN/30-39% 3D, 50-59% BDY BRN/40-49% 3D, 50-59% BDY BRN/50-59% 3D, 6,7 benzomorphan, 60-69% BDY BRN/10-19% 3D, 60-69% BDY BRN/20-29% 3D, 60-69% BDY BRN/3 DEG NOS, 60-69% BDY BRN/30-39% 3D, 60-69% BDY BRN/40-49% 3D, 60-69% BDY BRN/50-59% 3D, 60-69% BDY BRN/60-69% 3D, 70-79% BDY BRN/10-19% 3D, 70-79% BDY BRN/20-29% 3D, 70-79% BDY BRN/3 DEG NOS, 70-79% BDY BRN/30-39% 3D, 70-79% BDY BRN/40-49% 3D, 70-79% BDY BRN/50-59% 3D, 70-79% BDY BRN/60-69% 3D, 70-79% BDY BRN/70-79% 3D, 7B4 Antigen, 80-89% BDY BRN/10-19% 3D, 80-89% BDY BRN/20-29% 3D, 80-89% BDY BRN/3 DEG NOS, 80-89% BDY BRN/30-39% 3D, 80-89% BDY BRN/40-49% 3D, 80-89% BDY BRN/50-59% 3D, 80-89% BDY BRN/60-69% 3D, 80-89% BDY BRN/70-79% 3D, 80-89% BDY BRN/80-89% 3D, 8B-[(Methylthio)methyl]-6-propylergoline Monomethanesulfonate, 9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine Hydrochloride, 9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate, 90% + BDY BRN/10-19% 3RD, 90% + BDY BRN/20-29% 3RD, 90% + BDY BRN/30-39% 3RD, 90% + BDY BRN/3D DEG NOS, 90% + BDY BRN/40-49% 3RD, 90% + BDY BRN/50-59% 3RD, 90% + BDY BRN/60-69% 3RD, 90% + BDY BRN/70-79% 3RD, 90% + BDY BRN/80-89% 3RD, 90% + BDY BRN/90% + 3RD, B, B, B 859-35, B Cell, B cell acquired immunodeficiency, B cell activating factor, B Cell Childhood Acute Lymphoblastic Leukemia, B Cell Chronic Lymphocytic Leukemia, B cell differentiation factor, B Cell Differentiation Factor I, B cell inborn immunodeficiency, B Cell Linker Protein, B cell lymphoma, B Cell Lymphoma Stage II, B Cell Lymphoma Stage III… , (+ -)-Carbovir, (+)-6-((4-Chlorophenyl)-1H-1,2,4-triazol-1-ylmethyl)-1-methyl-1H-benzotriazole, (+)-Camptothecin, (+)-Catechin, (+-)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone Hydrochloride, (+-)-1-(4-(4-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-1H-imidazole Mononitrate, (-)-2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3R,4S)-3-hydroxy-1-methyl-4-piperidinyl]-4H-1-benzopyran-4-one Hydrochloride, (-)-Cholesterol, (-)-Cyclophosphamide, (4-carboxyphthalato)(1,2-diaminocyclohexane)-platinum(II), (CH3)2CHCH2CH3, *Catalytic Activity, *Catalytic Concentration, *Catalytic Content, *Catalytic Fraction, *Catalytic Rate, *Coefficient, *Constant, 1 carbon compound, 1 carbon transferase, 1-(2-chloroethyl)-1-nitroso-3-(D-glucos-2-yl)urea, 1-(2-Chloroethyl)-3-(2,6-Dioxo-3-Piperidyl)-1-Nitrourea, 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea, 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine, 1-(4-(2-Cyclopropylmethoxy)ethyl)phenoxy)-3-))1-methylethyl)amino)-2-propanol, 1-(4-chlorobenzoyl)-5-methoxy- 2-methyl-1-H-indole-3-acetic acid, 1-(5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide, 1-Chloro-2,3-epoxypropane, 1-Chloroisobutylene, 1-cyclohexyl-1-phenyl-3-pyrrolidino-1-propanol Hydrochloride, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, 1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, Monohydrochloride, Monohydrate, 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid, 1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole, 1-[(4-Chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine, 1-[(4-Chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine Dihydrochloride Monohydrate, 1-[2-{(4-chloro-phenyl)methoxy}-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole Mononitrate, 1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate, 1-[[5-[[2-(Carboxymethyl)-3-[[decahydro-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]methoxy]-4-methoxy-1,4-dioxobutoxy]methyl]decahydro-5,8a-dimethyl-2-methylene-1-naphthalenyl]methoxy]-1,2,3-propanetricarboxylic Acid, 1,2-Dimethyl Ester, 10-((3-Chloro-4-methoxyphenyl)methyl)-6-methyl-3-(2-methylpropyl)-16-(1-(3-phenyloxiranyl)ethyl)-1,4-dioxa-8,11-diazacyclohexadec-13-ene-2,5,9,12-tetrone, 10-chloro-4-hydroxy-6-methyl-2-phenyl-3,6-diazabicyclo[5.4.0]undeca-2,8,10,12-tetraen-5-one, 10^9 Cells/L, 13 cis retinoate, 13-CRA/5-FU/IFN-A/IL-2, 13-CRA/FLUT/LEUP, 13-CRA/IFN-A, 13-CRA/IFN-A/IL-2, 13-CRA/IFN-A/VIT-E, 13-CRA/IFN-B, 13-CRA/PCB, 13-CRA/TMZ, 13-CRA/VIT-E, 14 Carbon, 17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium, 2'3' cyclic nucleotide phosphodiesterase, 2-(4-Chlorophenoxy)-2-methylpropanoic acid ethyl ester, 2-CdA/CLB, 2-CdA/CTX/PRED, 2-CdA/IDA, 2-CdA/VP-16, 2-Chlorallyl Diethyldithiocarbamate, 2-Chloro-1,3-butadiene, 2-Chloro-1-(difluoromethoxy)-1,1,2-trifluoroethane, 2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)-phenothiazine, 2-Chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine Edisylate, 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine, 2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine Monohydrochloride, 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz(b,f)(1,4)oxazepine Succinate(1:1), 2-Chloro-4-Phenylphenol, 2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine, 2-Chloroethyl-3-Sarcosinamide-1-Nitrosourea, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, 21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate, 21-Chloro-9-fluoro-11beta,16alpha,17-trihydroxypregn-4-ene-3,20-dione Cyclic 16,17-Acetal with Acetone, 24 COMP WEEKS GESTATION, 25-26 COMP WKS GESTATION, 27-28 COMP WKS GESTATION, 29-30 COMP WKS GESTATION, 2C4, 2CDA, 3'-C-Ethynylcytidine, 3'5' cyclic nucleotide phosphodiesterase, 3'5'-cyclic ester of AMP, 3,5 cyclic AMP synthetase, 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine, 3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine monohydrochloride, 3-Chloroprocainamide, 3-[(3-(2-carboxyethyl)-4-methylpyrrol-2-yl)methylene]-2-indolinone, 3.2% Citrate, 3.2% Citrate, 3.8% Citrate, 3.8% Citrate, 31-32 COMP WKS GESTATION, 311C90, 33-34 COMP WKS GESTATION, 35-36 COMP WKS GESTATION, 4-(3Chloro-4-flurophenylamine)-7-methoxy-6(3-(4morpholinyl)quinazoline, 4-carboxyphenyl retinamide, 4-Chloroamphetamine, 4-[3-(2-Chloro-10H-phenothiazin-10-yl)propyl]-1-piperazineethanol, 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, 5-Chloro-2,4-pyridinediol, 5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine, 51 chromium release assay, 520C9x22 Bispecific Antibody, 566C80, 6-Chloro-2,3,4,5-tetrahydro-1-(p-hydroxyphenyl)-1H-3-benzazepine-7,8-diol methanesulfonate(salt), 6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide, 6-Chloro-9-((4-(diethylamino)-1-methylbutyl)amino)-2-methoxyacridine Dihydrochloride, 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone, 7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one, 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide, 7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride, 7-Chloro-5-(2-chlorophenyl)-1, 3-Dihydro-3-Hydroxy-1,4- Benzodiazepin-2-one, 7-Chloro-7-deoxylincomycin, 7-Chloro-7-deoxylincomycin Hydrochloride, 776C85, 776C85/5-FU, 776C85/CF/5-FU, 8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-1,3,5-naphthalenetrisulfonic Acid Hexasodium Salt, 8-Chloro Cyclic AMP, 8-Chloro-6-(2-fluorophenyl)-1-Methyl- 4H- Imidazo(1,5a)(1,4)Benzodiazepine, 8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine, 9,11-Conjugated Linoleic Acid, 9-Chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-pivalate, 9-cis-Retinoic Acid/Interferon Alfa, 9-cis-Retinoic Acid/Tamoxifen, 908, C, c, C, C & S NEC, C & S NOS, C & S-BILI/PANCREAS, C & S-BLOOD, C & S-ENDOCRINE, C & S-ENT/LARYNX, C & S-EYE, C & S-FEMALE GENITAL, C & S-INTEGUMENT, C & S-LOWER GI, C & S-LOWER RESP, C & S-LOWER URINARY, C & S-LYMPH SYSTEM, C & S-MUSCULOSKELETAL, C & S-NERVOUS SYST, C & S-OP WOUND, C & S-PERITONEUM, C & S-SPLEEN/MARROW, C & S-UPPER GI, C & S-UPPER URINARY, c abl, C cadherin, C Cell Adenocarcinoma with Amyloid Stroma, C Cell Carcinoma, C Chemokine, C elegans, C element, c erbA, c erbB, C fiber, c fms, c fos, c fps, c int2, c jun, c JUN kinase, c K ras, c kit, c mas, c myb, c new, C pylori, C reactive protein, C Reactive Protein, c sis, c src, C(1)-C(4) level spinal cord injury, unspecified, C(1)-C(4) level with central cord syndrome, C(1)-C(4) level with complete lesion of spinal cord, C(1)-C(4) level with other specified spinal cord injury, C(1)-C(4) quadriplegia and quadriparesis, complete, C(1)-C(4) quadriplegia and quadriparesis, incomplete, C(5)-C(7) level spinal cord injury, unspecified, C(5)-C(7) level with central cord syndrome, C(5)-C(7) level with complete lesion of spinal cord, C(5)-C(7) level with other specified spinal cord injury, C(5)-C(7) quadriplegia and quadriparesis, complete, C(5)-C(7) quadriplegia and quadriparesis, incomplete, C-52, C-C Chemokine Receptor D6, C-C Chemokine Receptor Type 11, C-C Chemokine Receptor Type 5, C-C Chemokine Receptor Type 9, C-Cell, C-Cell Hyperplasia, C-ERBA-ALPHA-1, c-erbB-1… (+)-DX 52-1, (+-)-1-(2,4-Dichloro-beta-((4-chlorobenzyl)thio)phenethyl)imidazole Nitrate, (+-)-15-Deoxyspergualin, (-)-.DELTA.9-Tetrahydrocannabinol, (-)-2'-Deoxy-5-fluoro-3'-thiacytidine, (1,1-Dimethylethyl)-4-methoxyphenol, (3,4-Dihydro-2-(4-methoxyphenyl)-1-naphthalenyl)(4-(2-(1-pyrrolidinyl)ethoxy)phenyl) Methanone, (6-D-(2-Naphthyl)alanine)LHRH Acetate, (Dichloromethylene)bisphosphonic Acid, (Diethylenetriamine)pentaacetic acid, (DMSO), *Difference, *Dilution Factor (Titer), .delta.-Aminolevulinic acid hydrochloride, .delta.1-Cortisone, 1 DEG BURN BACK OF HAND, 1 DEG BURN FINGR W THUMB, 1'-Demethyl-1'-nitroso-nicotine, 1, 5-dihydro-5-methyl-1-(5-O-phosphono-.beta.-D-ribofuranosyl)-1,4,5, 6,8-pentaazaacenaphthylen-3-amine, 1,1'-(2,3-Dimethyl-1,4-butanediyl)bis(3,4-dimethoxybenzene), 1,1'-Dichlorodimethyl Ether, 1,1-Dichloro-2-chloroethylene, 1,1-Dimethylbiguanide, 1,1-Dimethylbiguanide Hydrochloride, 1,1-Dimethylhydrazine, 1,11-Dichloro-6-[2-(diethylamino)ethyl]-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl)-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole-5,7(6H)-dione, 1,2 diazole, 1,2 dihydroxybenzene, 1,2,3,4-Dibenzopyrene, 1,2,4,5-Dibenzopyrene, 1,2,5,6 dianhydrogalactitol, 1,2,5,6-Dibenzacridine, 1,2,5,6-Dibenzanthracene, 1,2,6,7-Dibenzopyrene, 1,2,7,8-Dibenzacridine, 1,2,7,8-Dibenzopyrene, 1,2-diammino-methy lcyclobutane-platinum (II) lactate, 1,2-Dibromo-3-chloropropane, 1,2-Dibromoethane, 1,2-Dibromopropan-3-ol, 1,2-Dichloroethane, 1,2-Dihydro-3-methyl-benz(j)aceanthrylene, 1,2-Dihydro-4-hydroxy-N,1-dimethyl-2-oxo-3-quinolinecarboxanilide, 1,2-Dihydroxypropane, 1,2-Dimethylhydrazine, 1,2-Dithia-5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50-hexadecaazacyclotripentacontane, Cyclic Peptide Derivative, 1,2-Dithia-5,8,11,14,17-pentaazacycloeicosane Cyclic Peptide Deriv, 1,2-Dithioglycerol, 1,2-Dithiole-3-thione, 1,25-Dihydroxy-16-ene-23-yne-Vitamin D3, 1,25-Dihydroxyvitamin D3 Receptor, 1,2:15,16-Diepoxy-4,7,10, 13-tetraoxahexadecane, 1,3 diazine, 1,3-Diamino-4-methoxybenzene Sulphate, 1,3-Diamino-4-methylbenzene, 1,3-diazaspiro(4,5)decane-2,4-dione,3-(2-(bis-chloroethyl)amino)ethyl, 1,3-Diaziridino-2,4,6-Triaza-1,3,5,5-Tetraaminomethyl-1,3,5-Triphosphorin, 1,3-Dichloro-1-propene, 1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione, 1,3-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9, 10-anthracenedione Dihydrochloride, 1,3-Diisocyanatomethylbenzene, 1,3-Dimethyl-3-phenyl-2,5-dioxopyrrolidine, 1,3-Dimethylxanthine Monohydrate, 1,3-Dinitrato-2,2-bis(nitratomethyl)propane, 1,3-Dinitro-4-chlorobenzene, 1,3-Diphenyl-1-triazene, 1,4 diazine, 1,4 Diethylene Ether, 1,4-Diamino-2,3-dicyano-1,4- bis(2-aminophynyltio)butadiene, 1,4-Dichlor-B, 1,4-Dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic Acid, 1,4-Dimethyl-2,3-benzphenanthrene, 1,4:3,6-Dianhydro-D-glucitol 5-nitrate, 1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one, 1,5-Dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one Monosodium Salt, 1,6-Dinitropyrene, 1,7-Dihydro-6H-purine-6-thione, 1,8-Dihydroxy-9(10H)-anthracenone, 1,8-Dinitropyrene, 1,9-Dihydro-2-amino-9-(4-hydroxy-3-(hydroxymethyl)butyl)-6H-purin-6-one Monosodium Salt, 1-(11-Dodecylamino-10-Hydroxyundecyl)-3,7-Dimethylxanthine, 1-(2,3-Dideoxy-beta-glycero-pent-2-enofuranosyl)thymine, 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol, 1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil, 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil, 1-(3,4-Dimethoxybenzoyl)-4-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)piperazine, 1-(3,4-Dimethoxyphenyl)-2-propene, 1-(4-(1,1-Dimethylethyl)phenyl)-3-(4-methoxyphenyl)-1,3-propanedione, 1-De(5-oxo-L-proline)-2-de-L-glutamine-5-L-methioninecaerulein, 1-Deamino-8-D-arginine Vasopressin, 1-Deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt), 1-Deoxy-1-(methylamino)-D-glucitol 3-((((3-(acetylmethylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoyl)amino)acetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoate, 1-Deoxy-1-(methylamino)-D-glucitol 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)benzoate, 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole, 1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole Mononitrate, 1-[2-[4-(3,4-Dihydro-6-methoxy-2-phenyl-1-naphthalenyl)phenoxy]ethyl]pyrrolidine Hydrochloride, 1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Monohydrobromide, 10 day report, 10 days, 10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide, 10,11delta-Amitriptyline Hydrochloride, 10-(3-(Dimethylamino)propyl)phenothiazine Monohydrochloride, 10-Deacetyltaxol, 11D10, 11D10 Anti-Idiotype Vaccine, 14-Diethoxyacetoxydaunorubicin, 15 day report, 15-Deoxyspergualin Hydrochloride, 17,21-Dihydroxypregn-4-ene-3,11,20-trione, 17-Demethoxy-15-methoxy-11-O-methylgeldanamycin, (15R)-, 17d, 18d, 19d, 1D1O Anti-lymphoma Antibody, 2 DEG BURN BACK OF HAND, 2 DEG BURN FINGR W THUMB, 2 Dimensional Gel Electrophoresis, 2',3'-Dideoxyadenosine, 2',3'-Dideoxycytidine, 2',3'-Dideoxyinosine, 2'-Deoxy-5-azacytidine, 2'-Deoxy-5-trifluoromethyluridine, 2'-Deoxycytidine Kinase, 2'-Deoxythymidine, 2'3' dideoxy 3' thiacytidine, 2'3' dideoxynucleoside, 2, 4-Dioxopyrimidine, 2,2',2'',2''''-[(4,8-Dipiperidinopyrimido-[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol, 2,2'-Dichloro-4,4'-methylenedianiline, 2,2'-Dithio-bis-ethanesulfonate, Disodium Salt, 2,3 dimercaptosuccinic acid, 2,3-Dibromo-1-propanol Phosphate(3:1), 2,3-Dihydro-1H-imidazo(1,2-b)pyrazole, 2,3-Dihydro-3-hydroxy-2-imino-6-(1-piperidinyl)-4-pyrimidinamine, 2,3-Dihydroxy-2-(1-methylethyl)butanoic Acid (2,3,5,7a-tetrahydro-1-hydroxy-1H-pyrrolizin-7-yl)methyl Ester N-Oxide, 2,3-Dihydroxybutanedioic Acid, 2,4 dinitrophenol, 2,4,D/2,4,5,T, 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine, 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine Sulfate (2:1), 2,4-Diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline mono-D-glucuronate, 2,4-Diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine, 2,4-Dichloro-1-(4-nitrophenoxy)benzene, 2,4-dihydroxy-5-methylpyrimidine, 2,4-Dioxo-5-fluoropyrimidine, 2,6 dimethoxyphenylpenicillin, 2,6-Diamino-3-(phenylazo)-pyridine Hydrochloride, 2-((2,3-Dimethylphenyl)amino)benzoic Acid, 2-((2,6-Dichlorophenyl)amino)-benzeneacetic Acid, Monopotassium Salt, 2-(2-(Diethylamino)ethoxy)-3-phenylpropiophenone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one, 2-(3,4-Dihydroxyphenyl)ethanol, 2-(3,7,11,15,19,23,27,31,35,39-Decamethyl-2,6,10,14,18,22,26,30,34,38-tetracontadecanyl)-5,6-dimethoxy-3-methyl-2,5-cyclohexadiene-1,4-dione, 2-(4-(((3,5-Dimethylanilino)Carbonyl)Methyl)Phenoxy)-2-Methylpropionic Acid, 2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide Monohydrochloride, 2-(DIETHYLAMINO)ETHANOL, 2-(Diethylamino)ethyl 3-amino-4-propoxybenzoate Monohydrochloride, 2-(Diethylamino)ethyl p-aminobenzoate Monohydrochloride, 2-(Difluoromethyl)-DL-ornithine, 2-(Difluoromethyl)-dl-ornithine Hydrochloride, Monohydrate, 2-Deoxy-2-(3-methyl-3-nitrosoureido)-D-glucopyranose, 2-Deoxyphenobarbital, 2-Diethylaminoethyl 4-amino-2-chlorobenzoate Hydrochloride, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid, 2-[(2,6-Dichlorophenyl)amino]benzeneacetic Acid Monosodium Salt, 2-[3-(Dimethyl-amino)propyl]-8,8-diethyl-2-aza-8-germaspiro[4,5]decane, 3 day report, 3 DEG BRN W LOSS LEG-MLT, 3 DEG BRN W LOSS-LEG NOS, 3 DEG BRN W LOSS-LOW LEG, 3 DEG BURN BACK OF HAND, 3 DEG BURN FINGR W THUMB, 3 DEG BURN W LOSS-ANKLE, 3 DEG BURN W LOSS-FOOT, 3 DEG BURN W LOSS-KNEE, 3 DEG BURN W LOSS-THIGH, 3 DEG BURN W LOSS-TOE, 3' deoxyadenosine, 3', 5'-Dichloroamethopterin, 3',4'-Didehydro-4'-deoxy-C'-norvincaleukoblastine, 3'-Deoxyadenosine-5'-(tetrahydrogen triphosphate), 3,12-Diaza-6,9-diazoniadispiro(5.2.5.2)hexadecane, 3,12-bis(3-chloro-2-hydroxypropyl)-, dichloride, 3,3'-Diindolymethane, 3,3'-Dimethoxybenzidine, 3,3'-Dimethyl-4,4'-biphenyldiamine, 3,3-Dichloro-(1,1-Biphenyl)-4,4-Diamine, 3,4 dihydroxyphenylacetate, 3,4,5,6-Dibenzocarbazole, 3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione, 3,4-Dihydro-2-amino-6-methyl-4-oxy-5-(4-pyridylthio)-quinazoline Dihydrochloride, 3,4-dihydro-3-methyl-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide, 3,4-dihydroxy-4'-methyl-5-nitrobenzophenone, 3,4-Dihydroxybenzohydroxamic acid, 3,4-Dihydroxyphenylethanol, 3,5-Diacetamido-2,4,6-triiodobenzoic Acid, Sodium Salt, 3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide, 3,5-dichloro-2,4-dimethoxy-6-(trichloromethyl) pyridine, 3,6-Dinitro-2-phenyl-4H-1-benzopyran-4-one, 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione… (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic Acid, (+-)-1-Ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid, monohydrochloride, (+-)-4'-(4-(Ethylheptylamino)-1-hydroxybutyl)methanesulfonanilide Fumarate(2:1)(salt), (+/-)-13-Ethyl-17alpha-hydroxy-18,19-dinorpregn-4-en-20-yne-3-one, (-)-Ephedrine, (-)-Epigallocatechin 3-gallate, (-)-Epothilone B, (2E)-5-[3-[(Phenylsufonyl) Aminol Phenyl]-pent-2-en-4-ynohydroxamic Acid, (2E,4E,6E,8E)-9-(4-Methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-2,4,6,8-nonatetraenoic Acid, Ethyl Ester, (2E,4E,6R)-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide, (9E)-Erythromycin, 9-[O-[(2-methoxyethoxy)methyl]oxime], (E)-(3aS,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S,4RS)-3-hydroxy-4-methyl-1-octen-6-ynyl)-delta(sup 2(1H),delta)-pentalenevaleric Acid, (E)--1-[4'-(2-dimethylaminoethyoxy)phenyl]-1(3-hydroxyphenyl)-2-phenyl-but-1-ene, (E)-2-Butenedioic Acid, (E)-2-Butenedioic Acid, Dimethyl Ester, (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic Acid, Monomethanesulfonate, (E)-3,7-Dimethyl-2,6-octadien-1-ol, (E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol, (E)-4,4'-(1,2-ethenediyl)-bisphenol bis(dihydrogen phosphate), (E)-4-[2-[4-[2-(5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]phenoxy]ethyl]morpholine, (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol, (E)-6-((E)-3-(1-Pyrrolidinyl)-1-p-tolylpropenyl)-2-pyridineacrylic Acid, (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine, (E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine Hydrochloride, (E)-N-methyl-N-(1-naphthylmethyl)-3-phenyl-2-propen-1-amine-hydrochloride, (E)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide, (E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione, (E,E)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol, *Entitic, *Entitic Catalytic Activity, *Entitic Number, *Entitic Substance of Amount, *Entitic Volume, 1 EXTRAOC MUSCL ADVANCE, 1 EXTRAOC MUSCL RESECT, 1 EYE-SEV/OTH-BLIND NOS, 1,2-Epoxyethane, 1,2-Epoxyethylbenzene, 1,2-Epoxypropane, 1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-, Monohydrochloride, 1,3,5(10)-Estratrien-2,3-diol-17-one, 1,3,5(10)-Estratrien-3-ol-17-one, 1,3-Ethylene-2-thiourea, 1,4-Epoxy-1,3-butadiene, 1-Epoxyethyl-3,4-epoxycyclohexane, 1-Ethyl N4-sulfanilylcytosin, 1-Ethyl-1-nitrosourea, 1-ethyl-2-[3-ethyl-5-(3-methylbenzothiazolin-2-yliden)-4-oxothiazolidin-2-ylidenemethyl] pyridinium chloride, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone Monohydrochloride, Monohydrate, 1-[2-[4-[(1E)-1-(4-Iodophenyl)-2-phenyl-1-butenyl]phenoxy]ethyl]pyrrolidine, 10-EdAM, 13-Ethyl-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-17-ol, 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 3-((1E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,1, 2,3-Epoxy-1-propanol, 2-(3-ethylureido)-6-methylpyridine, 2-Ethyl-4-pyridinecarbothioamide, 3' 5' exonuclease, 3' exonuclease, 3-Ethyl-3-methylpyrrolidine-2,5-dione, 3-ethyl-5-phenyl-2,4-imidazolidinedione, 4, 8-Ethenopyrrolo[3',4':3,4]cyclobut[1,2-f]isoindole-1,3,5,7(2H, 6H)tetrone, octahydro-, 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one, 5' 3' exonuclease, 5' exonuclease, 5-Ethyl-5-phenyl-2,4,6(1H,3H,5H)-pyrimidinetrione, 5-Ethynyl-2,4(1H,3H)-pyrimidinedione, 6,7-Epoxytropine Tropate, 6-Ethoxy-2,2,4-trimethyl-1,2-dihydroquinoline, 7-Ethyl-10-Hydroxycamptothecin, 70% Ethanol, 7E11-C5.3-GYK-DTPA, 9-Ethyl 6-Mercaptopurine, E, E Coli Infection, E COLI SEPTICEMIA, E O9, E protein, E wave, E-code as reason for visit, E-F1, E-mail, E-Mail Address (for backward compatibility), E-stopped, E. coli, E. COLI INFECT NOS, E0167, E1A Binding Protein p300 Gene, E1A Enhancer-Binding Protein E1AF, E1A Lipid Complex, E2(17)KB 2, E26 Transformation Specific Oncogene, E2A, E2F Transcription Factor 1, E2F Transcription Factor 1 Gene, E3 ligase, E6, E7, E7(86-93) Lipopeptide, E7(86-93) Lipopeptide/HPV-16 E7(12-20) Peptide Vaccine/Montanide ISA-51, E7010, E7070, E7070/Irinotecan, E7389, E74-Like Factor 3, E74-Like Factor 3 (ETS Domain Transcription Factor, Epithelial-Specific) Gene, EA/L-PAM, EAA, EAA receptor, EAC/ACK _ Automated equipment command, Each, EAN/ACK _ Automated equipment notification, EAP1, Ear, Ear, EAR, Ear - Middle Ear (MMHCC), Ear and Labyrinth Disorder Class, EAR ANOM NEC/IMPAIR HEAR, EAR ANOMALIES NEC, ear bone, Ear bone, incus, Ear bone, malleus, Ear bone,stapes, ear cancer, Ear Carcinoma, ear disorder chemotherapy, ear disorder diagnosis, Ear Drum, ear hair cell, ear infection, Ear Injury, Ear Lobe, ear nose throat surgery, Ear pain/earache, Ear Part, ear pharmacology, EAR PIERCING, EAR PROBLEMS NEC, ear prosthesis, Ear Skin, ear surgery, ear tissue preservation, Ear wax (cerumen), Ear wax (cerumen), EAR/ACK _ Automated equipment response, ear/hearing prosthesis, EAR2 Protein, Earache, Early, early childhood, EARLY COMPLIC TRAUMA NEC, EARLY CONG SYPH SYMPTOM, EARLY CONGEN SYPH LATENT, EARLY CONGEN SYPH NOS, early detection, early detection for oral cancer, early detection of endometrial cancer, early detection of gastric cancer, early detection of lung cancer, early detection of neuroblastoma, early detection of ovarian cancer, early detection of prostate cancer, early detection of skin cancer, early detection of testicular cancer, early embryonic stage, early experience, Early Gastric Cancer, early intervention, Early Invasive Cervical Adenocarcinoma, Early Invasive Cervical Squamous Cell Carcinoma, EARLY ONSET DELIV-UNSPEC, EARLY ONSET DELIVERY-DEL, early onset disorder, Early onset of delivery, early onset schizophrenia, Early or threatened labor, early payment fee, Early Placenta Insulin-Like Peptide, early response gene, Early Response Protein NAK1, EARLY SATIETY, EARLY SKIN YAWS NEC, EARLY SYPH LATENT RELAPS, EARLY SYPHIL LATENT NOS, Early syphilis, symptomatic, Early tray, Early Yaws, earthquake, earthworm, EAST EQUINE ENCEPHALITIS, East Indian, East Timor, Eastern Abenaki, Eastern Band of Cherokee Indians of North Carolina, eastern dog tick, eastern equine encephalitis virus, Eastern Keres Pueblo, Eastern Orthodox, Eastern Shawnee Tribe of Oklahoma, EasternAlgonquin… 1-(3-Furanyl)-4-hydroxy-1-pentanone, 1-(4-fluorophenyl)-3(R)-[3-(4-fluorophenyl)-3(S)-hydroxypropyl]-4(S)-(4-hydroxyphenyl)-2-azetidinone, 1-fluoro-2,4-dinitrobenzene, 1-Fluoroethene, 10% Formalin, 10% Formalin, 14-3-3 Family, 18F-FHBG, 18FDG, 2'-Fluoro-2',3'-Dideoxyadenosine, 2-F-ara-AMP, 2-Fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene, 2-Fluoro-9-beta-arabinofuranosyladenine, 2-Fluoro-alpha-methyl-4-diphenylacetic Acid Sodium Salt, 2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid, 2F1, 3-(4-(1-formylpiperazin-4-yl)-benzylidenyl)-2-indolinone, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1H,3H]-quinazolinedione, 309 F, 3F8, 5 fluorodeoxycytidine, 5 fluorouridine, 5-Fluoro-1-(tetrahydro-2-furanyl)-2,4(1H,3H)-pyrimidinedione, 5-Fluoro-2-Deoxycytidine, 5-Fluoropyrimidinone, 5-Fluorouracil/epi, 5-Formyl Tetrahydrofolate, 5-Formyl-5,6,7,8-tetrahydrofolic Acid, 5-FU/FUDR, 5-FU/G-CSF/HU/IFN-A, 5-FU/G-CSF/IFN-A, 5-FU/GAN, 5-FU/HMM/MITO, 5-FU/HU, 5-FU/HU/IFN-A, 5-FU/HU/IUDR, 5-FU/HU/TAX, 5-FU/ICI D1694, 5-FU/ICRF-159/MeCCNU, 5-FU/IFN-A, 5-FU/IFN-A/IL-2, 5-FU/IFN-A/MITO, 5-FU/IFN-A/PALA, 5-FU/IFN-B, 5-FU/IL-1B, 5-FU/IUDR, 5-FU/L-CF, 5-FU/L-CF/LEV, 5-FU/L-CF/MTX, 5-FU/L-OHP, 5-FU/L-PAM, 5-FU/L-PAM/TMX, 5-FU/LEV, 5-FU/LEV/MOAB 17-1A, 5-FU/MeCCNU, 5-FU/MeCCNU/SZC/VCR, 5-FU/MeCCNU/VCR, 5-FU/MITO, 5-FU/MITO/MTX, 5-FU/MITO/SZC, 5-FU/MITO/VCR, 5-FU/MMPR/PALA, 5-FU/MTX, 5-FU/MTX/PALA, 5-FU/MTX/PRED/TSPA/VBL, 5-FU/MTX/TMX, 5-FU/MTX/TMX/TSPA, 5-FU/MTX/TSPA, 5-FU/MTX/VBL, 5-FU/MTX/VCR, 5-FU/PALA, 5-FU/PBA, 5-FU/PRED/VCR, 5-FU/SMS 201-995 pa, 5-FU/SZC, 5-FU/TAU, 5-FU/TAX, 5-FU/TMTX, 5-FU/TXT, 5-FU/VNB, 5-FU/VP-16, 5-[5-fluoro-2-oxo-1,2-dihydroindol-(3Z)-ylidenemethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide), 5FU/Leucovorin, 5FU/Leucovorin/Gemcitabine, 5FU/Leucovorin/Irinotecan, 5FU/Leucovorin/Levamisole, 6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic Acid, 9-Fluoro-11-beta,21-dihydroxy-16-alpha-methylpregna-1,4-diene-3,20-dione, 9-Fluoro-11beta,17-dihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 17-acetate, F, F, F, F 1686, F factor, F Test, F- element, F-actin, F-box and WD-40 Domain Protein 7 (Archipelago Homolog, Drosophila) Gene, F-SRC-1, F1 hybrid disease, F18 isotope, F19 isotope, F31 grant, F32 grant, FA, FA/LMTX, FAA/IL-2, Fab domain, FAB L2, Fabavirus, FABMS, FABP Family Gene, FABP1, FABP1, FABP2, FABP3, FABP4, FABP5, fabric, Fabrol, face, FACE & NECK INJURY, face cancer, face expression, Face Injury, face neoplasm, Face or brow presentation of fetus, Face or brow presentation, antepartum, Face or brow presentation, delivered, Face or brow presentation, unspecified as to episode of care, face-to-face, Facet Joint, Facial Artery, FACIAL BONE DX PROC NEC, FACIAL BONE INCISION NEC, FACIAL BONE RECONSTR NEC, FACIAL BONE REPAIR NEC, FACIAL BONE SEQUESTRECT, FACIAL BONE X-RAY NEC, Facial bone, inferior nasal concha, Facial bone, lacrimal, Facial bone, maxilla, Facial bone, nasal, Facial bone, palatine, Facial bone, vomer, Facial bone, zygomatic, FACIAL BONE/JNT OP NEC, facial muscle, FACIAL NERVE DIS NEC, FACIAL NERVE DIS NOS, Facial Nerve Ganglion, FACIAL NERVE INJ-BIRTH, facial nerve motor nucleus, Facial Nerve Neoplasm, Facial Nerve Nucleus, Facial Nerve Paralysis, Facial paralysis/Bells palsy, Facial Plastic Surgery, facial reconstruction, FACIAL RHYTIDECTOMY, Facial Vein, FACIAL WEAKNESS, FACILIT INTRAOC CIRC NEC, Facilitation of intraocular circulation, facility design, Facility ID, facility renovation, Facility type, facioscapulohumeral muscular dystrophy, FACS, FACS, facsimile, Facsimile data, FACTITIOUS DIS W SYMPTOM, FACTITIOUS ILL NEC/NOS, Factive, Factor II Deficiency, factor P, Factor VIII Related Antigen, Factor XII Deficiency, factor XIIIa, Factrel, faculty, FAD, FADD, FADD, Faeroe Islands, FAIL FORCEPS NOS-ANTEPAR, FAIL INDUCT NOS-ANTEPART, FAIL INDUCTION NOS-DELIV, FAIL INDUCTION NOS-UNSP, FAIL INTROD/REMOVE TUBE, FAIL MECH INDUCT-ANTEPAR, FAIL MECH INDUCT-DELIVER, FAIL MECHAN INDUCT-UNSP, FAIL STERILE CATHETER, FAIL STERILE ENDOSCOPY, FAIL STERILE HEART CATH, FAIL STERILE INJECTION, FAIL STERILE PERFUSN NEC… (gamma), (Glycolato-O,O')diammineplatinum(II), .gamma.-(p-bis(2-chloroethyl)aminophenyl)butyric acid, 1-[5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid, 14G2A, 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic Acid, 40083, 40148, 40148, G, g, g, G Alpha Interacting Protein, G Antigen Family D, Protein 3, G Beta Gamma, G Cell Neoplasm, G protein, G protein coupled receptor, G protein coupled receptor kinase, G Protein Gene, G Protein Pathway Suppressor 1 Gene, G Protein Pathway Suppressor 2, G Protein Pathway Suppressor 2 Gene, G Protein, Beta-2 Subunit, G Protein, Beta-3 Subunit, G Protein-Coupled Receptor 109B Gene, G Protein-Coupled Receptor 17, G Protein-Coupled Receptor 17 Gene, G Protein-Coupled Receptor 32, G Protein-Coupled Receptor 32 Gene, G Protein-Coupled Receptor 39, G Protein-Coupled Receptor 39 Gene, G Protein-Coupled Receptor 54, G Protein-Coupled Receptor 54 Gene, G Protein-Coupled Receptor 68, G Protein-Coupled Receptor 68 Gene, G Protein-Coupled Receptor Gene, G Protein-Coupled Receptor Kinase 1 Gene, G Protein-Coupled Receptor Kinase 1B, G Protein-Coupled Receptor Kinase 4 Gene, G Protein-Coupled Receptor Kinase 5 Gene, G Protein-Coupled Receptor Kinase 6 Gene, G Protein-Coupled Receptor Kinase 7 Gene, G Protein-Coupled Receptor Kinase Gene, G Protein-Coupled Receptor Kinase Interactor 1 Gene, G Protein-Coupled Receptor Kinase Interactor 2 Gene, G Protein-Coupled Receptor Kinase-Interactor 1, G Protein-Coupled Receptor, Family C, Group 5, Member C, G Protein-Coupled Receptor, Family C, Group 5, Member C Gene, G(q) Alpha, G(s) Alpha, G-actin, G-CSF, g/24.h, g/l, g/m2, g/m3, g/mL, G0 phase, G1, G1, G1, G12 grant, G15 Protein, G17DT, G2, G2, G20 grant, G207, G22P1, G28-5 sFv-PE40, G3, G3, G3Fax Image, G4, G6PD, G6PD deficiency, GA, Ga, Ga67 isotope, Ga68 isotope, GAB2, GAB2, GABA aminotransferase, GABA receptor, GAC1, GADD45 Gene Product, GADD45A, GADODIAMIDE, gadolinium, Gadolinium Texaphyrin, GADOTERIDOL, Gadoversetamide, GAG, gag gene related protein, GAG Protein, gag(glycosaminoglycan), gagging, gait, GAL-8, galactan, galactitol, GALACTOCELE, galactokinase, galactolipid, galactorrhea, Galactorrhea, antepartum condition or complication, Galactorrhea, postpartum condition or complication, Galactorrhea, with delivery, with mention of postpartum complication, Galactorrhea, with delivery, with or without mention of antepartum condition, galactosamine, galactose, galactose 1 phosphate uridylyl transferase deficiency, galactose 1 phosphate uridylyltransferase, Galactose Metabolism, galactose oxidase, galactosemia, galactoside, Galactosyltransferase, galanin, Galanin Receptor 2, Galanin Receptor 2 Gene, Galectin 3 Binding Protein, Galena Village (aka Louden Village), Gall Bladder, GALLAMINE TRIETHIODIDE, GALLBLADDER ANASTOM NEC, Gallbladder Body, gallbladder cancer, Gallbladder Cancer Stage I, Gallbladder Cancer Stage II, Gallbladder Cancer Stage III, Gallbladder Cancer Stage IV, Gallbladder Cancer Stage IVA, Gallbladder Cancer Stage IVB, Gallbladder Cancer Unresectable, Gallbladder Cancer, Localized, Gallbladder Cancer, Recurrent, Gallbladder Epithelium, Gallbladder Fundus, Gallbladder Hyperplastic Polyp, Gallbladder Injury, Gallbladder Kaposi Sarcoma, Gallbladder Leiomyoma, Gallbladder Leiomyosarcoma, Gallbladder Lipoma, Gallbladder Lymphoma, Gallbladder Malignant Melanoma, Gallbladder Neck, Gallbladder Neoplasm, Gallbladder Neurofibroma, Gallbladder Oat Cell Carcinoma, Gallbladder Pancreatic Heterotopia, Gallbladder Papillary Adenocarcinoma, Gallbladder Papillomatosis, Gallbladder Pleomorphic Spindle and Giant Cell Adenocarcinoma, Gallbladder Polyp, Gallbladder Rhabdomyosarcoma, Gallbladder Sarcoma, Gallbladder Signet Ring Cell Carcinoma, Gallego, Gallium nitrate, Gallium Nitrate/Hydroxyurea, Gallium Nitrate/Ifosfamide/Vinblastine, Gallium Nitrate/Paclitaxel, Gallium Scan, gallon (Queen Anne's wine gallon), GALLSTONE ILEUS, GalNAc(beta 1->4)-[NeuAc(alpha 2->8)NeuAc(alpha 2->3)]Gal(beta 1->4)GlcCer, GALT, galvanometry, Galzin, GAMBIAN TRYPANOSOMIASIS, gambling, GAMBLING AND BETTING, gamete, gamete intrafallopian transfer, gamete transport, gametogenesis, Gamimune N, gamma aminobutyrate, gamma benzopyrone, gamma camera, gamma carboxyglutamate, gamma counter, gamma globin, gamma globulin, Gamma Glutamyl Transferase, gamma glutamyltranspeptidase, gamma hydroxybutyrate, gamma hydroxyglutamate, Gamma Interferon, Gamma Interferon (GEN), gamma knife, Gamma Motor Neuron, Gamma Oryzanol, Gamma Radiation, gamma renin, gamma secretase, Gamma Tubulin… (-)-Hydromorphone, (.+-.)-Hexestrol, (1)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylene Dipivalate Hydrochloride, (1-Hydroxyethylidene)bisphosphonic Acid, (1H-Indol-3-ylmethyl)carbamodithioic Acid, Methyl Ester, 1 hour post challenge, 1(2H)-Phthalazinone Hydrazone, 1(2H)-Phthalazinone, 4-((4-Chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, Monohydrochloride, 1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-, 1(3-hydroxy-2-phosphonomethoxypropyl) Cytosine, 1(3H)Isobenzofuranone,6,7-dimethoxy-3-(5,6,7,8-tetrahydro-4-methoxy-6-methyl-1,3,-dioxolo(4,5-g)isoquinolin-5-yl)-hydrochloride, 1,1,1,2,2,2-Hexachloroethane, 1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane, 1,1-Hydrazodibenzene, 1,4,5,6,7,7-Hexachloro-5-norbornene-2,3-dicarboxylic Acid, 1,7-Heptanediyl Ester Sulfamic Acid, 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol, 1-(4'-Hydroxy-3'-coumarinyl)-1-phenyl-3-butanone, 1-Hexadecanaminium, N-(2-(((4-methoxyphenyl)methyl)-2-pyrimidinylamino)ethyl)-N,N-dimethyl-, Bromide, 1-Hexadecanol, 10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-,(E)-2-butenedioate(1:1), 12 hours, 12 hours post challenge, 12-HETE, 13-Hydroxydaunomycin, 13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolinium, 14-Hydroxydaunorubicin Hydrochloride, 15H-Pyrrolol[2,1-f][1,15,4,7,10,20]dioxatetraazacyclotri-cosine, Cyclic Peptide Deriv. (9CI), 166 Holmium-DOTMP, 17 hydroxycorticosteroid, 17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate, 1H-1,2,3-Triazole-4-carboxamide, 5-amino-1-((3,5-dichloro-4(4-chlorobenzoyl)phenyl)methyl), 1H-1,2,4-Triazol-3-Amine, 1H-1,4-Benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, Monopotassium Salt, compound with Potassium Hydroxide, 1H-Benz(de)isoquinolin-1-one, 2-(3S)-1-azabicyclo(2.2.2)oct-3-yl-2,3,3a,4,5,6-hexahydro-, Monohydrochloride,(3aS)-, 1H-benz(de)isoquinoline-1,3(2H)-dione, 5-amino-2-(2-(dimethylamino)ethyl), 1H-benzimidazol-2-ylcarbamic Acid Methyl Ester, 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-,(3R)-, Butanedioate(1:1), 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-, 1H-Imidazole, 1-(2-((7-chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-, Mononitrate, 1H-Imidazole, 4,5-dihydro-2-(1,2,3,4-tetrahydro-1-naphthalenyl)-, Monohydrochloride, 1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, Monohydrochloride, 1H-Imidazole-1-acetamide, N-(2-hydroxyethyl)-2-nitro-, 1H-Imidazole-2-methanamine, 4,5-Dihydro-N-phenyl-N-(phenylmethyl)-, Phosphate(1:1), 1H-imidazole-4-carboxamide, 5-(3,3-dimethyl-1-triazenyl)-, 1H-Imidazole-5-Carboxylic Acid, 1-((1R)-1-phenylethyl)-, Ethyl Ester, 1H-Imidazole-5-carboxylic Acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-,(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl Ester, 1H-imidazo[4,5-f]quinoline, acetamide deriv, 1H-Indene-3-acetic Acid, 5-Fluoro-2-methyl-1-((4-(methylsulfonyl)phenyl)methylene), (Z), 1H-Indole-2-carboxylic Acid, 1-(2-((1-(ethoxycarbonyl)butyl)amino)-1-oxopropyl)octahydro-,(2S-(1(R*(R*))2alpha,3abeta,7abeta))-, compound with 2-Methyl-2-propanamine(1:1), 1H-Indole-3-butanoic Acid, 1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-, Monobenzoate, 1H-indole-3-methanol, 1H-Purin-6-amine, 1H-Purin-6-amine, 2-fluoro- (9CI), 1H-Purine-2,6-diamine, 1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-, compound with 1,2-Ethanediamine(2:1), 1H-Purine-2,6-dione, 7-(2,3-dihydroxypropyl)-3,7-dihydro-1,3-dimethyl, 1H-Pyrazole, 4-methyl-, 1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2((5-methyl-1H-imidazol-4-yl)methyl)-, Monohydrochloride, 2 1/2 hours post challenge, 2 hours, 2 hours post challenge, 2 hydroxyacid oxidase, 2(1H)-pyridinone, 4-hydroxy-1-beta-D-ribofuranosyl, 2(1H)-Pyrimidinone, 4-amino-1-((2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)-, 2(1H)-Pyrimidinone, 4-amino-1-[4, 5-dihydroxy- 3-(hydroxymethyl)-2-cyclopenten-1-yl]-, 2(1H)-Pyrimidinone, 4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-,(2R-cis)-, 2(1H)-pyrimidinone, tetrahydro-4-hydroxy-1-beta-D-ribofuranosyl-, 2(1H)-Quinolinone, 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-, 2(H)-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, Monohydrochloride, 2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropionitrile), 2,3,9,10,11,12-Hexahydro-3-hydroxy-9-methoxy-8-methyl-10-(methylamino)-8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)triinden-1-one, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(2-Methylpropyl)-5-(2-propenyl)-, 2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-Ethyl-5-(1-methylbutyl), Monosodium Salt, 2-(1-H-imidazol-4-yl) Ethylamine Dihydrochloride, 2-(1-Hexyloxyethyl)-2-Devinyl Pyropheophorbide-a, 2-Hydroxy-1,2,3-propanetricarboxylic Acid, 2-Hydroxy-1,2,3-propanetricarboxylic Acid, Calcium Salt (2:3), 2-Hydroxy-1,2,3-propanetricarboxylic Acid, Potassium Salt, 2-Hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide, 2-Hydroxy-4-methoxybenzophenone, 2-Hydroxy-5-[[4-[(2-pyridinylamino)sulfonyl]phenyl]azo]benzoic Acid, 2-Hydroxyamino-2-ethanal, 2-Hydroxybenzoic Acid, 2-Hydroxypropanoic Acid Sodium Salt, 2-[[(Hexadecycloxy)hydroxyphosphinyl]oxy]-N,N,N-trimethylethanaminium Inner Salt, 24 Hour Extended Release Suspension, 24 hours, 24 hours post challenge, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-Dihydro-3-(phenylmethyl)-6-(trifluoromethyl)-, 1,1-Dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-Dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-2-methyl-3-(((2,2,2-trifluoroethyl)thio)methyl)-, 1,1-Dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-Dioxide, 2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(dichloromethyl)-3,4-dihydro-, 1,1-Dioxide, 2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-, 2H-1,4-Benzodiazepine-2-thione, 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-, 2H-1-Benzopyran-2-one, 2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, Tartrate, 2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-, 2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-, 2H-pyran-2-one,5,6-dihydro-6-(3,6,13-trihydroxy-3-methyl-4-(phosphonooxy)-1,7,9,11,-tridecatetraenyl)-,trans, 2T- hours, 3 hours post challenge, 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 17-(Acetyloxy)-6-chloro-1,2-dihydro-, (1beta,2beta)-, 3-(3-Hydroxyanthraniloyl)alanine, 3-(4-Hydroxyphenyl)-2H-1-benzopyran-7-ol, 3-(Hydroxynitrosoamino)-L-alanine, 3-Heptanol, 6-(dimethylamino)-4,4-diphenyl-, Acetate (Ester), (3S,6S)-(-)-, 3-Hydroxy-2-phenyl-4H-1-benzopyran-4-one, 3-hydroxy-3-methylglutaryl-Coenzyme A Reductase, 3-Hydroxy-5-methoxy-6-methyl-2-pentyl-4H-pyran-4-one, 3-Hydroxy-alpha-methyl-L-tyrosine, 3-Hydroxyestra-1,3,5(10),7-tetraen-17-one, 3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione) prop-beta-en-alpha-ol, 3H-1,2-Dithiole-3-thione, 4-methyl-5-pyrazinyl-, 3H-1,4-Benzodiazepin-2-amine, 7-chloro-N-methyl-5-phenyl, 4-oxide, 4 hours, 4 hours post challenge, 4 hydroxynonenal, 4 hydroxyphenylpyruvate dioxygenase, 4,4'-(3H-2,1-Benzoxathiol-3-ylidene)bis(2-bromo-3-methyl-6-(1-met-hylethyl)phenol) S,S-dioxide, 4-Hexenoic acid, 6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-, (E)-, 4-Hexylresorcinol, 4-HYDROXY BUTYRIC ACID, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 4-Hydroxy-2-methyl-N-2-pyridinyl-2H-1,2-benzothiazine-3-carboximide-1,1-dioxide, 4-hydroxy-3,7-dimethoxy-17-methylmorphin-7-en-6-one, 4-Hydroxyacetanilide, 4-Hydroxyandrost-4-ene-3,17-dione, 4-hydroxyanisole, 4-Hydroxytamoxifen, 4-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]-1,2-benzenediol Hydrochloride, 4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethylpiperidinium, Inner Salt, 4H-1-benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-8-methoxy-, 4H-1-benzopyran-8-acetic Acid, 4-Oxo-2-phenyl, 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-Tetrahydro-6-methyl-, Hydrochloride,(6aR)-, 4H-Imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic Acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, Ethyl Ester, 4H-Indol-4-one, 3-ethyl-1,5,6,7-tetrahydro-2-methyl-5-(4-morpholinylmethyl)-, Monohydrochloride, 4H-Pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, Dihydrochloride,(2R,4aR,5aR,6S,7S,8R,9S,9aR,10aS)-, 4H-Pyrano[3,2-g]quinoline-2,8-dicarboxylic Acid, 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-, Disodium Salt, 4H-Pyrazino(2,1-a)isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro-, 4H-Pyrido(1,2-a)pyrimidin-4-one, 9-methyl-3-(1H-tetrazol-5-yl)-, Potassium Salt, 4H-Pyrrolo(3,2-d)pyrimidin-4-one,1,5-dihydro-2-amino-7-(3-pyridinylmethyl), 5 hours post challenge, 5 hydroxytryptamine, 5,5'-[(2-Hydroxy-1,3-propanediyl)bis(oxy)]bis[4-oxo-4H-1-benzopyran-2-carboxylic Acid], Disodium Salt, 5-Heptenamide, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-,(5Z)-, 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-, 5-HIAA, 5-HT-3, 5-Hydroxy-6-methyl-3,4-pyridinedimethanol Hydrochloride, 5-Hydroxytryptamine (Serotonin) Receptor 2A Gene, 5-Hydroxytryptamine (Serotonin) Receptor 3A Gene, 5H-(1)Benzopyrano(2,3-b)pyridine-3-carboxylic Acid, 2-Amino-7-(1-methylethyl)-5-oxo-, 5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-, 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, Maleate(1:1), 5H-Dibenz(b,f)azepine-5-carboxamide, 5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, Hydrochloride, 5H-indolo(2,3-a)pyrrolo(3,4-c)carbazole-5,7(6H)-dione,1,11-dichloro-12,13-dihydro-12-(4-O-methyl-beta-D-glucopyranosyl), 5HT transporter, 6 hours, 6 hours post challenge, 6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone Hydrochloride, 6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidine-2-methanol,2,3,3a,9a-tetrahydro-3-hydroxy-6-imino-,(2R(2alpha,3beta,3a beta,9a beta)), 6H-Purine-6-thione, 2-amino-9-(2-deoxy-.alpha.-D-erythro-pentofuranosyl)-1,9-dihydro- (9CI), 6H-Pyrido[4, 3-b]carbazolium, 9-hydroxy-2,5,11-trimethyl-acetate (salt), 7 hours post challenge, 7H-benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl, 8 hours, 8 hours aligned on nursing shifts, 8 hours post challenge, 9H-Purine-9-acetaldehyde, .alpha.-(1-formyl-2-hydroxyethoxy)-1,6-dihydro-6-oxo-, (R-(R*, R*))- (9CI), 9H-Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-, 9H-Thioxanthene-2-sulfonamide, N,N-dimethyl-9-(3-(4-methyl-1-piperazinyl)propylidene)-, Dihydrochloride, Dihydrate, H, h, H, H and N, H antigen, H element, H SIMPLEX COMPLICAT NEC, H SIMPLEX COMPLICAT NOS, H SIMPLEX IRIDOCYCLITIS, H SIMPLEX KERATITIS, H SIMPLEX MENINGITIS, H SIMPLEX OTITIS EXTERNA, H ZOSTER COMPLICATED NEC, H ZOSTER COMPLICATED NOS, H ZOSTER IRIDOCYCLITIS, H ZOSTER KERATOCONJUNCT, H ZOSTER NERV SYST NEC, H ZOSTER NERV SYST NOS, H ZOSTER OTITIS EXTERNA, H+ element, H+ K+ ATPase, H+- transporting ATP synthase, H-2Q1, H-2RIIBP, h-NEU… (123-I)Sodium Iodide, (131-I)Sodium Iodide, (2-Isothiocyanatoethyl)benzene, (6-Isothiocyanatohexyl)benzene, 1 INT MAM-COR ART BYPASS, 1,3-Indandione, 2-(p-methoxyphenyl)-, 1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol Hydrochloride, 10i, 111 In-B3, 111 Indium, 11i, 125-Iodine, 12i, 131 I-MIBG, 131-I-Anti-B1 Monoclonal Antibody, 131-Iodine, 131I-HuCC49-deltaCH2, 131I-mAbF19, 13i, 14i, 15i, 16i, 17i, 17id, 17im, 18i, 18id, 18im, 19i, 19id, 19im, 1i, 2 INT MAM-COR ART BYPASS, 2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, Disodium Salt, 2-Imino-4-keto-5-phenyltetrahydrooxazole, 2-Isopropylaminopyrimidine, 20i, 21i, 22i, 23i, 24i, 25i, 26i, 27i, 28i, 29i, 2i, 3-Isoxazolecarboxylic Acid, 5-methyl-, 2-(phenylmethyl)hydrazide, 30i, 30id, 30im, 31i, 31id, 31im, 32i, 32id, 32im, 3i, 4,4'-[(4-Imino-2,5-cyclohexadien-1-ylidene)methylene]bisbenzenamine Monohydrochloride, 4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one, 4-Isoxazolecarboxamide, 5-Methyl-N-(4-(trifluoromethyl)phenyl)-, 4i, 5'-Inosinic Acid, Homopolymer Complex with 5'-Cytidylic Acid Homopolymer, 5-Iodo-2-pyrimidinone-2'-deoxyribose, 5-isoandrosterone, 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1), 5i, 6i, 7i, 8i, 9i, I, I, I & D PALMAR/THENAR SPAC, I 123 Monoclonal Antibody 81C6, I 124 Monoclonal Antibody A33, I 131 Antiferritin Immunoglobulin, I 131 Liothyronine, I 131 MOAB BC8, I 131 MOAB TNT-1/B, I 131 Monoclonal Antibody 3F8, I 131 Monoclonal Antibody 81C6, I 131 Monoclonal Antibody A33, I 131 Monoclonal Antibody CC49, I 131 Monoclonal Antibody G-250, I 131 Monoclonal Antibody Lym-1, I 131 Uptake, I cell disease, I Kappa B, I Kappa B A, I kappa B beta, I-123, I-124, I-CORONARY, I-Kappa-B-Epsilon, I01, I02, I03, I07, I01, I04, I02, I03, I04, I05, I05, I06, I06, I08, I09, I10, I11, I08, I09. I10, I11, I12, I13, I14, I15, I3A, IA, IACUC, IAP, IAP Family Gene, IAP Family Protein, IATROGEN CV INFARC/HMRHG, IATROGEN HYPOTHYROID NEC, IATROGEN PULM EMB/INFARC, IATROGENC HYPOTNSION NEC, Iatrogenic Cancer, IATROGENIC CARNITINE DEF, iatrogenic disease, Iatrogenic hypotension, Iatrogenic Kaposi Sarcoma, IATROGENIC PITUITARY DIS, IATROGENIC PNEUMOTHORAX, IATROGENIC THYROIDITIS, Ibandronate Sodium, Ibandronic Acid, IBC, IBD, Ibizan Hound, iboga alkaloid, ibogaine, Ibopamine, ibotenate, ibotenate receptor, IBP2, Ibritumomab Tiuxetan, Ibudilast, IC, IC, Ic351, ICAM, ICAM1, ICAM2, ICAM3, ICC, ICCS, ICD, ICD, ICD-10, ICD-10 Australian modification, ICD-10 Canada, ICD-10 Procedure Codes, ICD-9CM, ICD9, ICHPPC-2, ichthyotoxin, ICI 123215, ICI 176334, ICI 182,780, ICI 46,474, ICI 59118, ICI D1033, ICI D1694, ICI-118630, Iclaprim, ICM, ICN 1229, Icofungipen, Icon, Icotidine, ICP/MS, ICP47, ICR, ICRF-187, ICS 205-930, ICSH, Icterus, ICV, ID, ID2, IDA/L-ATRA, IDA/MP/MTX/PRED/VCR, Idarubicin HCl, IDEC C2B8 antibody, IDEC Y2B8, IDEC-114 Monoclonal Antibody/Rituximab, IDEC-In2B8/Rituximab, IDEC-In2B8/Rituximab/Yttrium Y 90 Ibritumomab Tiuxetan, Idem, Identical, identical twin, Identification, Identification problem, Identified, identified entity, Identifier, Identifier type, identity, IDENTITY DISORDER, Identity May Be Divulged… J, J, J segment gene, J-107088, J01, J02, J591, JA, Jaagsiekte Sheep Retrovirus, Jackson Rancheria of Me-Wuk Indians of California, Jacksonian epilepsy, Jacksonian Seizure, Jacobson's organ, jail, Jain, JAK kinase, JAK1, JAK2, JAK3, JAK3, JAM, Jamaica vomiting sickness, Jamaican, Jambul, Jamestown S'Klallam Tribe of Washington, Jamul Indian Village of California, Japanese, Japanese American, Japanese B virus, Japanese Chemistry, Japanese Chin, Japanese encephalitis, Japanese encephalitis virus, Japanese Image Examination Cache, Japanese Nationwide Medicine Code, JAR, JARID1B, jasmolin, jasmolone, Jaundice, JAUNDICE NOS, jaw, JAW DISEASE NEC, jaw fracture, Jaw Joint, Jaw Keratocyst, jaw movement, Jaw Osteonecrosis, Jaw sprain, Jaw symptoms/complaints, JB, JC Polyomavirus, JCML, JE, Jeghers-Peutz Syndrome, Jehovah's Witnesses, Jejunal Neoplasm, jejunectomy, jejunectomy/duodenectomy/ileectomy, jejunocolostomy, jejunoileal bypass, jejunoileostomy, Jejunum, Jejunum obstruction, JejunumRoute, jellyfish, Jemez, jen shen, Jena Band of Choctaw Indians, Louisiana, jerveratrum, Jewett-Marshall Stage B1 Bladder Cancer, Jewett-Marshall Stage B2 Bladder Cancer, Jewett-Marshall Stage D1 Bladder Cancer, Jewett-Marshall Stage D2 Bladder Cancer, Jewish, Jewish, Jewish: Conservative, Jewish: Orthodox, Jewish: Other, Jewish: Reconstructionist, Jewish: Reform, Jewish: Renewal, JHCHREAS, JHCHRGFR, JHCHRNEW, JHCHRPEN, JHCHRXME, JHCHRXMS, JHNUSCLM, JHNUSIND, JHNUSIND1, JHNUSIND5, JHNUSLBR, JHNUSMEM, JHNUSMEM5, JHNUSMEM6, JHNUSMLK, JHNUSPRE, JHNUSTKS, JHNUSTKS5, JHNUSVET, Jicarilla, Jicarilla Apache Tribe of the Jicarilla Apache Ind, jird, JIS-2022-JP, JLAC/JSLM, nationwide laboratory code, JM-216, JM-8, JM-9, JNK1 protein kinase, JO, Joacamine, Job, Job code, Job code/class, job performance, job satisfaction, job site, JOINT DIS NEC-ANKLE, JOINT DIS NEC-FOREARM, JOINT DIS NEC-HAND, JOINT DIS NEC-L/LEG, JOINT DIS NEC-MULT JTS, JOINT DIS NEC-OTH JT, JOINT DIS NEC-PELVIS, JOINT DIS NEC-SHLDER, JOINT DIS NEC-UP/ARM, JOINT DIS NOS-ANKLE, JOINT DIS NOS-FOREARM, JOINT DIS NOS-HAND, JOINT DIS NOS-L/LEG, JOINT DIS NOS-MULT JTS, JOINT DIS NOS-OTH JT, JOINT DIS NOS-PELVIS, JOINT DIS NOS-SHLDER, JOINT DIS NOS-UP/ARM, joint ligament, JOINT MOVEMENT TRAINING, Joint of the Pelvic Girdle, Joint of the Rib, Joint of the Vertebra, JOINT PAIN-ANKLE, JOINT PAIN-FOREARM, JOINT PAIN-HAND, JOINT PAIN-JT NEC, JOINT PAIN-L/LEG, JOINT PAIN-MULT JTS, JOINT PAIN-PELVIS, JOINT PAIN-SHLDER, JOINT PAIN-UP/ARM, Joint Photographic Experts Group, joint prosthesis, Joint replaced by other means, Joint replaced by other means, unspecified joint, JOINT REPLACED KNEE, JOINT REPLACED SHOULDER, JOINT REPLACED WRIST, joint replacement, Joint replacement of lower extremity, joint stiffness, joint stress, JOINT STRUCTURE OP NEC, Joint Swelling, JOINT SYMPT NEC-FOREARM, JOINT SYMPT NEC-MULT JTS, JOINT SYMPT NEC-UNSP JT, JOINT SYMPTOM NEC-ANKLE, JOINT SYMPTOM NEC-HAND, JOINT SYMPTOM NEC-L/LEG, JOINT SYMPTOM NEC-OTH JT, JOINT SYMPTOM NEC-PELVIS, JOINT SYMPTOM NEC-SHLDER, JOINT SYMPTOM NEC-UP/ARM, Joint Tuberculosis, Jones Kendrick Medium, Jones Kendrick Medium, Jones methenamine silver stain, Joubert syndrome, journal, Journalism, JPEG Image, Js, JT DERANGEMENT NEC-ANKLE, JT DERANGEMENT NEC-HAND, JT DERANGEMENT NEC-L/LEG, JT DERANGEMENT NEC-MULT, JT DERANGEMENT NOS-ANKLE, JT DERANGEMENT NOS-HAND, JT DERANGEMENT NOS-MULT, JT DERANGMENT NEC-OTH JT, JT DERANGMENT NEC-PELVIS, JT DERANGMENT NEC-SHLDER, JT DERANGMENT NEC-UP/ARM, JT DERANGMENT NOS-OTH JT, JT DERANGMENT NOS-PELVIS, JT DERANGMENT NOS-SHLDER, JT DERANGMENT NOS-UP/ARM, JT DERANGMNT NEC-FOREARM, JT DERANGMNT NEC-UNSP JT, JT DERANGMNT NOS-FOREARM, JT DERANGMNT NOS-UNSP JT… *Kinematic Viscosity, 130 kDa Retinoblastoma-Associated Protein, 150 kD Oxygen-Regulated Protein, 170-kD Melanoma Membrane-Bound Gelatinase, 21-kDa TBP-Like Protein, 28 kDa Heat Shock Protein, 3-ketobutyrate, 33kDa Phototransducing Protein, 34/67 kD Laminin Receptor, 350/400 kDa PCAF-Associated Factor, 510 (K), 510 (K) exempt, 55 kDa Erythrocyte Membrane Protein, 70 kDa Ribosomal Protein S6 Kinase 2, 70-kD Heat Shock Protein, 70-kD Heat-Shock Protein/MUC-1 Antigen, 72kD type IV Collagenase, 76 kD Tyrosine Phosphoprotein, 90 kDa Ribosomal Protein S6 Kinase 5, 95 kDa Melanocyte-Specific Secreted Glycoprotein, 98 kD Nucleoporin, K, K, K 252a, K cell, K+ element, K. PNEUMONIAE PNEUMONIA, K08 grant, K11, K12 Protein, K13, K15, K21, K22, K23 grant, K23, K24, K24 grant, K25 grant, K30 grant, K32ADPCM Audio, K8/K18, Kadish Stage A Olfactory Neuroblastoma, Kadish Stage B Olfactory Neuroblastoma, Kadish Stage C Olfactory Neuroblastoma, Kaguyak Village, Kaibab Band of Paiute Indians of the Kaibab Indian, kainate, kainate receptor, Kaktovik Village (aka Barter Island), Kala-Azar, Kalapuyan, Kalispel Indian Community of the Kalispel Reservat, kallidin II, kallikrein, Kallikrein 11 Gene, Kallikrein 15 Gene, Kallikrein 2, Prostatic Gene, Kallikrein 3, (Prostate Specific Antigen) Gene, kallikrein hypertension, KALLIKREIN INHIBITOR UNIT, KANAMYCIN, kangaroo, kangaroo rat, Kanien'kehaka, Kansa, Kansas, kaolin, Kaolin Pneumoconiosis, Kaposi Sarcoma NCI Grade 2, Kaposi Sarcoma NCI Grade 3, Kaposi Sarcoma-Associated Human Herpes Virus 8 Positive Extracavity Lymphoma, Kaposi's Sarcoma of Lung, Kaposi's Sarcoma of Palate, Kaposi's Sarcoma of Parotid, Kaposi's Sarcoma of Penis, Kaposi's Sarcoma of Prostate, Kaposi's Sarcoma of Rectum, Kaposi's sarcoma, lymph nodes, Kaposi's sarcoma, other specified sites, Kaposi's sarcoma, soft tissue, Kaposiform Hemangioendothelioma, kappa chain gene, kappa receptor, Karelian Bear Dog, karenitecin, Karnofsky, Karnofsky 20-30, Karnofsky 40-50, Karnofsky 60-70, Karnovsky's fixative, Karnovsky's fixative, Karok, Karuk Tribe of California, karyogram, Karyorrhexis, KASCHIN-BECK DIS NEC, KASCHIN-BECK DIS-ANKLE, Kaschin-Beck disease, Kaschin-Beck disease involving forearm, Kaschin-Beck disease involving hand, Kaschin-Beck disease involving lower leg, Kaschin-Beck disease involving multiple sites, Kaschin-Beck disease involving pelvic region and thigh, Kaschin-Beck disease involving shoulder region, Kaschin-Beck disease involving upper arm, Kashaya, Kashia Band of Pomo Indians of the Stewarts Point, kat, Kava, Kaw Nation, Oklahoma, Kawaiisu, Kayser, KAYSER-FLEISCHER RING, KAZ, KB cell, KCS, KCZ/TAX, KDR, KE, Kechan, Keeshond, Keflin, Kefzol, Keisho-To, Kell system, keloid, Kemadrin, Kemerovo virus, Kenaitze Indian Tribe, Kenalog, Kenny Caffey syndrome, Kentucky, kepone, Keppra, keratan sulfate, Keratan Sulfate Biosynthesis, keratin, Keratin 19 Gene, Keratin Filament, Keratin Pearls Formation, KERATIN RIDGE MUCOSA-MIN, Keratinizing Epidermoid Carcinoma in situ of Nasopharynx, Keratinizing Epidermoid Carcinoma of Nasopharynx, Keratinizing Primary Intraosseous Squamous Cell Carcinoma Arising de novo, Keratinizing Squamous Cell Carcinoma, Keratinocyte, Keratinocyte Differentiation, keratinocyte growth factor, Keratinocyte Growth Factor Therapy, Keratinous Cyst of Scrotum, keratitis, KERATITIS IN EXANTHEMA, KERATITIS NEC, Keratoacanthoma, keratocentesis, KERATOCONJUNCTIVIT SICCA, keratoconjunctivitis, KERATOCONJUNCTIVITIS NEC, keratoconus, KERATOCONUS, AC HYDROPS, KERATOCONUS, STABLE, Keratoderma, keratohyalin, keratomalacia, Keratomeleusis, Keratopathy, keratophakia, KERATOPROSTHESIS, keratosis, Keratosis of Larynx, Keratotic Basal Cell Carcinoma, Keratotic Plaque, Keratotic Vocal Cord, Keresan, Kerlone, Kernicterus due to isoimmunization of fetus or newborn, Kernicterus of fetus or newborn not due to isoimmunization, kerosene, Kerry Blue Terrier, ketal, Ketalar, KETAMINE, Ketamine HCl, Ketchikan Indian Corporation, Ketek, ketene, keto fatty acid, ketoaldehyde, ketogenesis, ketogenic, ketoglutarate dehydrogenase, ketone oxidoreductase, KETOROLAC TROMETHAMINE, ketosteroid, ketotic glycinemia, KETOTIFEN, Ketrax, Kevadon, Keweenaw Bay Indian Community of L'Anse and Ontona, Key… (-)-L-alpha-Hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic Acid, (Laparoscopic) adjustment of size of adjustable gastric restrictive device, *Length Increment, *Liquefaction, 125-L-Serine-2-133-interleukin 2, 15-Lipoxygenase, Reticulocyte Arachidonate, 177 Lu-CC49, 2 lysophosphatidylcholine acylhydrolase, 23-L-Leucinecolony-Stimulating Factor 2, 29-L-Argininamide-30-de-L-glutamine-31-de-L-glutamine-32-deglycine-33-de-L-glutamic acid-34-de-L-serine-35-de-L-asparagine-36-de-L-glutamine-37-de-L-glutamic acid-38-de-L-arginine-39-deglycine-40-de-L-alanine-41-de-L-arginine-42-de-L-alanine-43-de-L-argin, APETITU GALTZEA(ESKL. T06), L, L 694,458, L 705,126, L 735524, L 778,123, L cell, L form bacteria, L iditol dehydrogenase, L iduronate, L iduronidase, L NMMA, L selectin, L-12717, L-3-(3,4-Dihydroxyphenyl)-2-methylalanine Ethyl Ester Hydrochloride, L-377,202, L-5103, L-744,832, L-754030, L-778,123/Paclitaxel, L-791456, L-Asnase, L-Cell Glucagon-Like Peptide Producing Neoplasm, l-Deprenyl, L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl), L-Methionine, L-PAM/MePRDL, L-PAM/MePRDL/VCR, L-PAM/MNI, L-PAM/PCB/VBL, L-PAM/PRDL, L-PAM/PRED, L-PAM/PRED/VCR, L-PAM/TAX, L-PAM/TNF, L-PAM/TSPA, L-PAM/VCR, L-Phenylalanine, 4-hydroxy-, L-Sarcolysin, L-tryptophanase, L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, L/min, L/s, L0, L1, L1 Adult Acute Lymphoblastic Leukemia, L1 Vertebra, L2 Vertebra, L3 Vertebra, L4 Vertebra, L5 Vertebra, L6, L6, L651582, LA, La Crosse virus, La element, La Jolla Band of Luiseno Mission Indians of the La, La Posta Band of Diegueno Mission Indians of the L, La Raza, Lab, Lab, Lab Alert, Lab Findings, Lab Tech, lab test category, Lab to obtain specimen from patient, Label, Labeling, LABETALOL, Labetalol Hydrochloride, Labia, Labia Majora, Labia Minora, Labial frenectomy, LABIAL FRENOTOMY, Labial Mucosa, Labial Salivary Gland, LaBID, labor, Labor and Delivery, labor and delivery, Labor and industries number, labor complication, labor union, Laboratories, Laboratories; Clinical Medical Laboratory, Laboratories; Dental Laboratory, Laboratories; Physiological Laboratory, Laboratory, Laboratory, Laboratory, laboratory accident, laboratory accident/infection, Laboratory acknowledgment message (unsolicited), Laboratory Animal, Laboratory Animal Science, laboratory cat, LABORATORY EXAMINATION, laboratory facility, laboratory infection, Laboratory Management, Laboratory Management, Diplomate, laboratory mouse, Laboratory order message, Laboratory Procedure, laboratory rabbit, laboratory rat, laboratory study, labored breathing, LABYRINTH FISTULA COMB, labyrinthectomy, LABYRINTHINE DYSFUNC NEC, LABYRINTHINE DYSFUNC NOS, Labyrinthine fistula, labyrinthine fluid, labyrinthine membrane, Labyrinthitis, LAC CANALICULI PROBE, Lac Courte Oreilles Band of Lake Superior Chippewa, Lac du Flambeau Band of Lake Superior Chippewa Ind, LAC EYELID INV LACRM PAS, LAC EYELID SKN/PERIOCULR, lac operon, LAC PASSAGE MANIP NEC, LAC PUNCTUM OBLITERATION, Lac Vieux Desert Band of Lake Superior Chippewa In, laccase, LACER OF CERVIX-POSTPART, LACERAT OF CERVIX-DELIV, LACERAT OF CERVIX-UNSPEC, Laceration, LACERATION OF EYE NOS, Laceration of liver, major, with open wound into cavity, Laceration of liver, major, without mention of open wound into cavity, Laceration of liver, minor, with open wound into cavity, Laceration of liver, minor, without mention of open wound into cavity, Laceration of liver, moderate, with open wound into cavity, Laceration of liver, moderate, without mention of open wound into cavity, Laceration of lung with open wound into thorax, Laceration of lung without open wound into thorax, Laceration of spleen extending into parenchyma without mention of open wound into cavity, Laceration of spleen extending into parenchyma, with open wound into cavity, Laceration(s), liver, Laceration/cut, Lacertilla, LACK NORM PHYSIO DEV NOS, LACK OF ADEQUATE SLEEP, LACK OF COORDINATION, Lack of expect therapeutic effect, Lack of expected normal physiological development in childhood, LACK OF FOOD, LACK OF HOUSING, Lack of physical exercise, Lack of posterior occlusal support, LACK OF WATER, LACRIM CANALIC STENOSIS, LACRIM PASSAGE INCIS NEC, LACRIM PASSGE CHANGE NEC, Lacrimal, lacrimal apparatus, Lacrimal Artery, Lacrimal Bone, Lacrimal Canaliculus, Lacrimal Duct Obstruction, LACRIMAL FISTULA, Lacrimal Gland, LACRIMAL GLAND CYST NEC, Lacrimal Gland Mucoepidermoid Carcinoma, Lacrimal Gland Neoplasm, LACRIMAL MUCOCELE, Lacrimal Nerve, LACRIMAL PUNCTUM PROBE, Lacrimal Sac, LACRIMAL SAC STENOSIS, LACRIMAL SYS DX PROC NEC, LACRIMAL SYST DIS NEC, Lacrimal System Neoplasm, LACRIMAL SYSTEM OP NEC, LacrimalPunctaRoute, LACRIML PUNCTUM STENOSIS, Lactaid, lactalbumin, lactaldehyde dehydrogenase, lactam, LACTAT DIS NEC-ANTEPART, LACTAT DIS NEC-DEL W P/P, LACTAT DIS NOS-ANTEPART, LACTAT DIS NOS-DEL W P/P, LACTAT DIS NOS-POSTPART… (+-)-m-((Ethylamino)-1-hydroxyethyl)phenyl Pivalate, (+-)-Methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Hydrochloride, (+/-)-2-(1-Methylethyl)-4-(1-methylethylidene)-2-cyclohexen-1-ol, (+/-)-5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione, ( Z )-2-Butenedioate (1:1), (1-Methyl-DL-piperidine-2-carboxylic acid)-2,6-dimethylanilide hydrochloride, (10^3m)3, (2) m-[[3-(Ethoxymethyl)-5-fluoro-3,6-dihydro-2,6-dioxo-1(2H)-pyrimidinyl]carbonyl]benzoic Acid, 2-Ester with 2,6-Dihydroxynicotinonitrile Benzoate (Ester), (2-Mercaptoethyl)trimethylammonium Iodide S-ester with O,O-diethyl Phosphorothioate, Diethoxyphosphoryl-thiocholine Iodide, (2-Mercaptopropionyl)glycine, (99m)Tc-Medronate, (99m)Tc-P280, (Monomethoxypolyethylene Glycol Succinimidyl)74-L-Asparaginase, *Mass, *Mass Concentration, *Mass Concentration Ratio, *Mass Fraction, *Mass Increment, *Mass Rate, *Mass Ratio, 1 minute post challenge, 1 month (30 days) post challenge, 1,1'-[(methylethanediylidene)dinitrilo)diguanidine, 1,2-(methylenedioxy)benzene, 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol, 1-(3-Mercaptopropionic acid)-8-D-arginine Vasopression Monoacetate, 1-(3-Methylaminopropyl)dibenzo(b,e)bicyclo(2.2.2)octadiene Hydrochloride, 1-Methoxy-2-nitrobenzene, 1-Methyl-1-nitrosourea, 1-Methyl-3-nitro-1-nitrosoguanidine, 1-methylethyl-2-chloro-5-[[5,6-dihydro-2-methyl- 1, 4-oxathiin-3-yl-carbonyl]-amino]benzoate, 10 minutes post challenge, 10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine, 10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine Dihydrochloride, 10-[(1-Methyl-3-pyrrolidinyl)methyl]-10H-phenothiazine Hydrochloride, 10^3/mcl, 15 minutes post challenge, 17m, 18m, 19m, 2 minutes post challenge, 2 months (60 days) post challenge, 2,2'-Methylenebis(3,4,6-trichlorophenol), 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, Hydrochloride, (2R,6R,11R)-rel-, 2-(1-Methylethyl)-4-pentenamide, 2-(Methacryloyloxy)ethanol, 2-(Methoxycarbonyl)propene, 2-Mercaptoethanesulfonate, Sodium Salt, 2-Mercaptopyridine 1-oxide Zinc Salt, 2-Methoxy-5-Methylaniline, 2-Methyl-1,3-butadiene, 2-Methyl-3-(2-methylphenyl)-4(3H)-quinazolinone, 2-Methyl-3-o-tolyl-6-sulfamyl-7-chloro-1,2,3,4-tetrahydro-4-quinazolinone, 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine, 2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide, 2-methylacyl-CoA Racemase, 2-Methylallyl Chloride, 20 minutes post challenge, 25 minutes post challenge, 3 methoxy 4 hydroxyphenylethyleneglycol, 3 minutes post challenge, 3 months (90 days) post challenge, 3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one), 3,4 methylenedioxyamphetamine, 3,4 methylenedioxymethamphetamine, 3-(Methylseleno)-l-alanine, 3-methyl TTNEB, 3-Methyl-7-chloro-1,2,4-benzothiadiazine 1,1-Dioxide, 3-Methylglutaconyl-CoA Hydratase, 30 minutes post challenge, 30m, 31m, 32m, 4 minutes post challenge, 4'-Methylgenistein, 4,4'-Methylenebisbenzenamine, 4-(1-Methylethenyl)-1-cyclohexene-1-carboxylic Acid, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, 4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide, 4-(6-Methoxy-2-naphthalenyl)-2-butanone, 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone, 4-Methylphenol, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide, 4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide Monomethanesulfonate, 4-[4'-(Methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone, 5 methoxy N,N dimethyltryptamine, 5 methoxytryptamine, 5 methylcytosine, 5 minutes post challenge, 5,10 methylenetetrahydrofolate, 5,10-Methylenetetrahydrofolate Reductase (NADPH) Gene, 5-MeC, 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole, 5-Methoxy-N-acetyltryptamine, 5-methyltetrahydrofolate:NADP oxidoreductase, 6 minutes post challenge, 6-(methylmercapto)purine ribonucleoside, 6-Mercaptopurine Monohydrate, 6-Mercaptopurine ribonucleoside, 6-Methoxy-7,4'-dihydroxyisoflavone, 6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid, 6-Methyleneandrosta-1,4-diene-3,17-dione, 6-[(1-Methyl-4-nitro-1H-imidazol-5-yl)thio]-1H-purine, 7 minutes post challenge, 7-(1-Methylethoxy)-3-phenyl-4H-1-benzopyran-4-one, 8 minutes post challenge, 8-Methoxypsoralen, 8-methyl-6-piperidino-s-triazolo (4,3-b)Pyridazine, 8-MOP, 9 minutes post challenge, 9-[(3-Methyl-2-butenyl)oxy]-7H-furo[3,2-g][1]benzopyran-7-one, lower urinary tract, M, m, M, M & B 39831, M cell, m chlorophenylpiperazine, M Phase, M protein, M-Azidopyrimethamine, M-FA-142, m/c, m/c(2), M/R, M0, M01, M01, M02, M03, M04, M05, M06, M01, M02, M03, M04, M05, M06, M07, M08, M09, M10, M11, M02, M03, M04, M05, M06, M07, M08, M09, M1, M1 receptor, M10, M11, M12, M13, M15, M1a, M1b, M1c, M2 receptor, M3 receptor, M4, M4, M4-RT, M4-RT, M5, M5, MA, MAb, MabCampath, MabThera, MAC, MAC (Mycobacterium avium Complex), Mac Lagan unit, MAC Lymphadenitis, Macaca, Macaca mulatta, Macaca nemestrina, Macedonia, Macedonia, MACH ACC-OCC POWER BOAT, machine abstracting, MACHINE ACC-UNPOW BOAT, MACHINE ACCIDENT-SKIER, MACHINE ACCIDENT-SWIM, MACHINE DEPENDENCE NOS, machine indexing, Machine readable text document (HL7 V2.2 only), Machine readable text document (HL7 V2.3.1 and later), MACHINERY ACC-DOCKER, Machinery accident in water transport, Machinery accident in water transport injuring occupant of other watercraft — crew, Machinery accident in water transport injuring occupant of other watercraft — other than crew, Machinery accident in water transport injuring other specified person, Machinery accident in water transport injuring unspecified person, machining fluid, mackeral, MacNeal's tetrachrome blood stain, MACOP-B Regimen, Macracanthorhynchus, Macrobid, Macrocephaly, MACROCHEILIA, Macrocystic Neurilemmoma, Macrocyte, MACRODACTYLIA (FINGERS), MACRODACTYLIA OF TOES, Macrodactyly, Macrodantin, MACROGENIA, macroglia, macroglobulin, Macrolide… (+-)-N,alpha-Dimethylcyclohexaneethylamine, (+-)-N-Hydroxy-N-(1-benzo[b]thien-2-ylethyl)-urea, (+/-)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide, (-)-N -Methyl-3-phenyl-3-(o-tolyloxy)-propylamine Hydrochloride, (-)-Naloxone, (-)-Nicotine, (.+-.)-Noradrenaline, *Number, *Number Concentration, *Number Content, *Number Fraction, *Number Ratio, 1,8-Naphthyridine-3-carboxylic Acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-, 1,9-Nonanedioic Acid, 1,9-Nonanediol, 1-Naphthacenecarboxylic acid, 4-[[O-2,6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-O-2, 6-dideoxy-.alpha.-L-lyxo-hexopyranosyl-(1.fwdarw.4)-2,3, 6-trideoxy-3-(dimethylamino)-.alpha.-L-lyxo-hexopyranosyl]oxy]-2-e thyl-1,2,3,4,6,11-hexahydro-2,5,7,10, 1-Naphthalenemethanamine, a-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-,(aR)-, Hydrochloride, 1-NBaP, 1-Nitrobenzo[a]pyrene trans-7,8-Dihydrodiol, 1-Nitropyrene, 1-Nitrosopiperidine, 1-Nitrosopyrrolidine, 13-(N,N-Dimethylglycyl)brefeldin A, 19 nortestosterone, 2,2'-(Nitrosoimino)bisethanol, 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) Acetamide, 2-Naphthacenecarboxamide, 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-, Monohydrochloride,(4S-(4alpha,4aalpha,5alpha,5aalpha,12aalpha))-, 2-Naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride(4S-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-, 2-Naphthoic Acid, 4,4'-methylenebis(3-hydroxy-, ester with 2-(2-(4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl)-ethoxy)ethanol, 2-Nitro-N-(phenylmethyl)-1H-imidazole-1-acetamide, 2-Nitropropane, 2-[N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl]imidazoline, 2-[N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl]imidazoline Monomethanesulfonate, 2ND DEG BURN ABDOMN WALL, 2ND DEG BURN ANKLE, 2ND DEG BURN ARM NOS, 2ND DEG BURN ARM-MULT, 2ND DEG BURN AXILLA, 2ND DEG BURN BACK, 2ND DEG BURN BREAST, 2ND DEG BURN CHEST WALL, 2ND DEG BURN CHIN, 2ND DEG BURN EAR, 2ND DEG BURN ELBOW, 2ND DEG BURN EYE, 2ND DEG BURN FACE NEC, 2ND DEG BURN FINGER, 2ND DEG BURN FOOT, 2ND DEG BURN FOREARM, 2ND DEG BURN GENITALIA, 2ND DEG BURN HAND NOS, 2ND DEG BURN HAND-MULT, 2ND DEG BURN HEAD NOS, 2ND DEG BURN HEAD-MULT, 2ND DEG BURN KNEE, 2ND DEG BURN LEG NOS, 2ND DEG BURN LEG-MULT, 2ND DEG BURN LIP, 2ND DEG BURN LOWER LEG, 2ND DEG BURN MULT FINGER, 2ND DEG BURN MULT SITE, 2ND DEG BURN NECK, 2ND DEG BURN NOSE, 2ND DEG BURN PALM, 2ND DEG BURN SCALP, 2ND DEG BURN SCAPULA, 2ND DEG BURN SHOULDER, 2ND DEG BURN THIGH, 2ND DEG BURN THUMB, 2ND DEG BURN TOE, 2ND DEG BURN TRUNK NEC, 2ND DEG BURN TRUNK NOS, 2ND DEG BURN UPPER ARM, 2ND DEG BURN WRIST, 2ND DEGREE BURN NOS, 2ND DEGREE SUNBURN, 2nd non-Operative, 2ND OP POST EYE REM NEC, 2nd Operative, 2NDRY EXENT CAVITY GRAFT, 2NDRY OCULAR IMP INSERT, 3-Nitrobenzo[a]pyrene trans-7,8-Dihydrodiol, 4 nitroquinoline N oxide, 4-(Nitrooxy)butyl 2-fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetate, 4-Nitroestrone, 4-Nitropyrene, 4-Nitrosomorpholine, 5' nucleotidase, 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S-cis)-, hydrochloride, 5,12-Naphthacenedione, 7, 8, 9, 10-tetrahydro-6, 8, 11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-[[2, 3, 6-trideoxy-3-(4-morpholinyl)-.alpha.-L-lyxo-hexopyranosyl] oxy]-, hydrochloride, (8S-cis)-, 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride, 6-N-(1-hydroxymethyla-2-hydroxy)ethylamino-12,13-dihydro-13-(beta-D-gluco pyranosyl)-5H-indolo[2,3-a]-pyrrolol[3,4-c]-carbazole-5,7(6H)-dione, 6-NC, 6N HCL, 6N HCL, 7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C, 9-NC, 9-Nitro-20 (S-)Camptothecin, N, N, N, N acetyl glutamate synthetase deficiency, N acetyl glutamate synthethase deficiency, N acetyl L glutamate, N acetylgalactosamine, N acetylglucosamine, N acetylglucosaminidase, N acetylhexosamine, N acetylneuraminate, N acylaminoacid, N acylation, N alkylaminoacid, N carbamoylaminoacid, N element, N glycosidase, N hydroxyacetylaminofluorene, N hydroxylation, N methyl D aspartate, N methyl D aspartate receptor, N methylaminoacid, N methylnicotinamide, N phosphonoacetyl L aspartate, N,N,N',N',N"-pentamethyl-1,3,5-triazine, N,N-bis(carboxymethoxy)glycine, N,N-Dibenzyl Daunomycin, N-(((3,4-Dichlorophenyl)amino)carbonyl)-2,3-dihydro-5-benzofuransulfonamide, N-((6R,9S,10R,13S,15aS,18R,22S,24aS)-22-(p-(Dimethylamino)benzyl)-6-ethyldocosahydro-10,23-dimethyl-5,8,12,15,17,21,24-heptaoxo-13-phenyl-18-(((3S)-3-quinuclidinylthio)methyl)-12H-pyrido(2,1-f)pyrrolo(2,1-l)(1,4,7,10,13,16)oxapentaazacyclononadecin-9-yl)-, N-(2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, hydrochloride, N-(2-((5-((Dimethylamino)methyl)furfuryl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine, compound with bismuth(3(+)) citrate (1:1), N-(2-chloroethyl)-N-(1-methyl-2-phenoxyethyl)-benzenemethanamine, N-(2-Dimethylaminopropyl-1)phenothiazine Hydrochloride, N-(4-Methoxyphenyl)retinamide, N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide, N-(5-[N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic Acid, N-(Butylsulfonyl)-O-(4-(4-piperidinyl)butyl)-L-tyrosine Monohydrochloride, N-(N-(N-(N(2)-L-Arginyl-L-Lysyl)-L-alpha-Aspartyl)-L-Valyl)-L-Tyrosine, N-137, N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) Gene, N-Acetyltyrosine, N-butyl-N-(4-hydroxybutyl)nitrosamine, N-butyl-N-nitroso-1-butanamine, N-Hydroxy-N'-phenyloctanediamide, N-Lost, N-Methyl-N-Nitroso-Glycine, N-TRAF BOARD/ALIGHT-DRIV, N-TRAF BOARD/ALIGHT-PSGR, N-TRAF BRD/ALIGHT-MOCYCL, N-TRAF BRD/ALIT-ANIM RID, N-TRAF BRD/ALIT-MCYC PSG, N-TRAF BRD/ALIT-PED CYCL, N-TRAF BRD/ALIT-PEDEST, N-TRAF BRD/ALIT-PERS NEC, N-TRAF BRD/ALIT-PERS NOS, N-TRAF BRD/ALIT-ST CAR, N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]acetamide, N-[(5S)-6,7-Dihydro-9,10,11-trimethoxy-3-(phosphonooxy)-5H-dibenzo[a,c]cyclohepten-5-yl]acetamide, N-[1-(2-Cyano-2-deoxy-beta-D-arabinofuranosyl]-2-oxo-1,2-dihydropyrimidin-4-yl}hexadecanamide, N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide, N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine, N-[[4-[Bis(2-iodoethyl)amino]phenoxy]carbonyl]-L-glutamic Acid, N01, N02, N13 isotope, N15 isotope, N33, N43 grant, N44 grant, NA, NA, Na+ element, Na/H exchanger, NA17-A, Na24 isotope, NAACCR, Nabesna, NABI, NABI (formerly North American Biologicals, Inc.), NABILONE, Nabothian Cyst, NAD analog, NAD kinase, NAD phosphate, NAD transhydrogenase, NAD(+) ADP ribosyltransferase, NAD(H) analog, NAD(P)H Dehydrogenase, Quinone 1 Gene, NAD(P)H oxidoreductase, NADE, Nadene, NADH analog, NADH oxidoreductase, NADOLOL, NADPH cytochrome c2 reductase, NADPH dehydrogenase, NADPH Dependent Diflavin Oxidoreductase 1, NADPH oxidase, Nadroparin, Naegleria, Nafcil, NAFCILLIN… ((o-Carboxyphenyl)thio)ethylmercury, Sodium Salt, (o,p)-DDD, (o-Bromobenzyl)ethyldimethylammonium p-Toluenesulfonate, (OC-6-33)-dichlorodihydroxybis(2-propanamine)platinum, (OC-6-43)-bis(acetato)amminedichloro(cyclohexylamine)platinum, *Osmolality, .omega.-Diethylamino-2,6-dimethylacetanilide, 1 or More Positive Axillary Nodes, 1,1'-Oxybisethane, 1,12 (OH) D3, 1,2-Oxathiolane 2,2-Dioxide, 1,25 (OH) vitamin D, 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, 1-(2-Oxo-4-amino-1,2-dihydropyrimidin-1-yl)-2-deoxy-2,2-difluororibose, hydrochloride, 1-0-Octadecyl-2-O-methyl-Sn-3-glycero-phosphocholine Liposome, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine, 1-Octadecyl-2-methoxy-rac-glycero-3-phosphocholine, 10-O-Elsaminosylelsarosylchartarin, 12-O-tetradecanoylphorbol-13-acetate, 2,4-Oxazolidinedione, 3,5,5-trimethyl-, 2-Oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)methyl)-,(S)-, 2-Oxazolidinone, 5-((3,5-dimethylphenoxy)methyl)-, 2-Oxetanone, 2-oxo-N,3-bis-(2-chloroethyl) tetrahydro-2H-1,3,2-oxazaphosphorin- 2-amine, 22-Oxovincaleukoblastine, 3-(o-Methoxyphenoxy)-1,2-propanediol, 3-o-Chlorophenyl-5-methyl-4-isoxazolylpenicillin Sodium, 3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2, 3-oxobutyrate, 3-[[6-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one, 37 or more completed weeks of gestation, 4-o-Tolylazo-o-Toluidine, 4-Oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-(2-hydroxyethylidene)-7-oxo-, Monopotassium Salt,(2R-(2alpha,3Z,5alpha))-, 5-(o-Chlorobenzyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridinium Chloride, 6-O-Methylerythromycin, 6-[O-(1,1-Dimethylethyl)-D-serine]-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig) 2-(aminocarbonyl)hydrazide, 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide Luteinizing Hormone-Releasing Factor (Pig), 7-O-[(Methylthio)methyl]paclitaxel, 8-Oxo-2'-Deoxyguanosine, 8-Oxoguanine DNA Glycosylase, 8-Oxoguanine DNA Glycosylase Gene, O, O, o aminobenzoate, O antigen, O glycosidase, O methylglucose, O'nyong-nyong virus, O,O-diethyl-S-[2(diethylamino)ethyl]phosphorothioate, O-ethyl-S-[2(diethylamino)ethyl]ethylphosphonothioate, O-ethyl-S-[2(diethylamino)ethyl]methylphosphonothioate, O-ethyl-S-[2(diisopropylamino)ethyl]methylphosphonothioate, o-Phosphoric Acid, O01, O02, O03, O04, O05, O06, O08, O09, O10, O11, O25, O12, O26, O13, O14, O15, O15 isotope, O16, O17, O17 isotope, O18, O18 isotope, O19, O20, O21, O23, O24, O27, O28, O29, O30, O31, O32, O33, O34, O35, O36, O6-Benzylguanine/Polifeprosan 20 With Carmustine Implant, O6-benzylguanine/Temozolomide, OAF, Oat Cell, Oat Cell Cancer, Oat Cell Carcinoma of Extrahepatic Bile Duct, Oat Cell Carcinoma of Prostate, oat sterile dwarf virus, oats, OB AIR EMBOL-DELIV W P/P, OB AIR EMBOLISM-ANTEPART, OB AIR EMBOLISM-DELIVER, OB AIR EMBOLISM-POSTPART, OB AIR EMBOLISM-UNSPEC, OB INJ PELV ORG NEC-DEL, OB INJ PELV ORG NEC-UNSP, OB PELVIC HEMATOMA-DELIV, OB PELVIC HEMATOMA-UNSP, OB PERIN TRAUM NEC-UNSP, OB PERIN TRAUM NOS-UNSP, OB PERINEAL HEMATOM-UNSP, OB PERINEAL HEMATOMA-DEL, OB PERINEAL LAC NOS-DEL, OB PERINEAL LAC NOS-UNSP, OB PERINEAL TRAU NEC-DEL, OB PERINEAL TRAU NOS-DEL, OB PULM EMBOL NOS-UNSPEC, OB PULMON EMBOL NEC-UNSP, OB PYEM EMBOL-DEL W P/P, OB PYEMIC EMBOL-ANTEPART, OB PYEMIC EMBOL-DELIVER, OB PYEMIC EMBOL-POSTPART, OB PYEMIC EMBOL-UNSPEC, OB SURG COMP NEC-POSTPAR, OB SURG COMPL NEC-UNSPEC, OB SURG COMPL-DEL W P/P, OB TAMPONADE UTERUS/VAG, OB TRAUMA NEC-ANTEPARTUM, OB TRAUMA NEC-DEL W P/P, OB TRAUMA NEC-DELIVERED, OB TRAUMA NEC-POSTPARTUM, OB TRAUMA NEC-UNSPEC, OB TRAUMA NOS-ANTEPARTUM, OB TRAUMA NOS-DEL W P/P, OB TRAUMA NOS-DELIVERED, OB TRAUMA NOS-POSTPARTUM, OB TRAUMA NOS-UNSPEC, OB Ultrasound, obesity, Obesity (BMI >=30), Obesity complicating pregnancy, childbirth, or the puerperium, Obesity complicating pregnancy, childbirth, or the puerperium, antepartum condition or complication, Obesity complicating pregnancy, childbirth, or the puerperium, delivered, with mention of postpartum complication, Obesity complicating pregnancy, childbirth, or the puerperium, delivered, with or without mention of antepartum condition, Obesity complicating pregnancy, childbirth, or the puerperium, postpartum condition or complication, Obesity complicating pregnancy, childbirth, or the puerperium, unspecified as to episode of care or not applicable, OBJ W-W/O SUB FALL NEC, Object, Object Identifier, object recognition, object shape, Objective, Objective functional tests of eye, OBJECTIVE TINNITUS, Oblimersen/Paclitaxel, Oblimersen/Rituximab, Obliteration and total excision of vagina, Obliteration of vaginal vault, OBR group, OBS CHR BRONC W AC BRONC, OBS CHR BRONC W(AC) EXAC, OBS DFCT REN PLV&URT NOS, OBS/EVAL EXP BIOL NEC, OBS/EVAL SUS EXP ANTHRAX, OBSC AFRIC CARDIOMYOPATH, OBSERV FOLLOWING RAPE, OBSERV-ACCIDENT NEC, Observation, observation, Observation Alert, Observation and evaluation for other specified suspected conditions, Observation and evaluation for suspected conditions not found, Observation and evaluation of newborns for suspected condition not found, Observation batteries master file, Observation following accident at work, Observation following other inflicted injury, Observation for abuse and neglect, Observation for adult antisocial behavior, Observation for childhood or adolescent antisocial behavior, Observation for other suspected mental condition, Observation for suspected cardiovascular disease, Observation for suspected malignant neoplasm, Observation for suspected mental condition, Observation for suspected respiratory condition, Observation for suspected tuberculosis, Observation for unspecified suspected mental condition, Observation Result Handling, Observation result status codes interpretation, observation series, ObservationAllergyTestType, ObservationDiagnosisTypes, ObservationIndicationType, ObservationInterpretation, ObservationInterpretationChange, ObservationInterpretationExceptions, ObservationInterpretationNormality, ObservationInterpretationSusceptibility, ObservationIssueTriggerCodedObservationType, ObservationIssueTriggerMeasuredObservationType, ObservationMethod, Observations/Performed Service to follow, ObservationSequenceType… (+)-2-(2-((p-Chloro-alpha-methyl-alpha-phenylbenzyl)oxy)ethyl)-1-methyl Pyrrolidine Fumarate, (+)-2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate(1:1), (-)-Phenylisopropylmethylpropynylamine, (.+ -.)-p-Isobutylhydratropic acid, (p-Methoxyphenyl)trithiopropene, *Pressure (Partial), 1,1',1"-phosphinothioylidynetrisaziridine, 1,10-(1,2-Phenylene)pyrene, 1,2,3-Propanetricarboxylic Acid, 2-hydroxy-, Gallium-(sup 67)Ga(1:1) Salt, 1,2,3-Propanetriol, 1,2,3-Propanetriyl Butanoate, 1,2-Propyleneimine, 1,3-Propanediol, 2-((3-fluoranthenylmethyl)amino)-2-methyl-, 1,3-Propanediol, 2-Amino-2-(hydroxymethyl)-, 1,3-Propanediol, 2-methyl-2-propyl-, Dicarbamate, 1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-, Phosphate (1:2), 1,4-Phenylenebis(methylene)selenocyanate, 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate, 1-(p-Acetylbenzenesulfonyl)-3-Cyclohexylurea, 1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine Hydrochloride, 1-(p-Chlorophenyl)-5-isopropylbiguanide Hydrochloride, 1-(p-Hydroxyphenyl)-2-(1'-methyl-2'-phenoxy)ethylaminopropanol-1 Hydrochloride, 1-p-beta-dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene, 1-p-carboxy-3,3-dimethylphenyltriazine, 1-phenyl-2-diethyl-amino-1-propanone Hydrochloride, 1-Phenyl-Methyl-2-Piperazinyl-1H-Benzimidazole Hydrochloride, 1-Phosphatidylinositol 3-Kinase, 1-Phosphatidylinositol 3-Kinase, 1-Phosphatidylinositol Phosphodiesterase, 1-Phosphatidylinositol-4,5-Bisphosphate Phosphodiesterase Beta 3, 1-Phosphatidylinositol-4-Phosphate 5-Kinase, 1-Phosphatidylinositol-4-Phosphate Kinase, 1-Piperazinecarboxamide, 4-(6-Methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-, 1-Piperazineethanol, 4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)-(9CI), 1-Piperidinepropanoic Acid, 4-(methoxycarbonyl)-4-((1-oxopropyl)phenylamino)-, Methyl Ester, Monohydrochloride, 1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, Hydrochloride, 1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, Chloride, 1-Propanol, 3,3'-, dimethanesulfonate (ester), hydrochloride, 1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-, Hydrochloride, 1-Propanone, 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-, 1-Propanone, 2-methyl-1,2-di-3-pyridinyl-, 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-, 1-Propanone,1-(4-butoxyphenyl)-3-(1-piperidinyl)-,hydrochloride, 1-Pyrrolidineethanamine, beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-, Monohydrochloride, 10-(2-Propynyl)estr-4-ene-3,17-dione, 10-Propargyl-10-Deazaaminopterin, 10p, 10pd, 10pm, 11p, 11pd, 11pm, 12p, 12pd, 12pm, 13p, 13pd, 13pm, 14-3-3 Protein Tau, 14p, 14pd, 14pm, 15p, 15pd, 15pm, 16p, 16pd, 16pm, 17p, 17p, 17p12, 17pd, 17pm, 18p, 18pd, 18pm, 19p, 19pd, 19pm, 1p, 1p, 1pd, 1pm, 2 PAM, 2 propylvalerate, 2, 5-Piperazinedione, 3,6-bis-(5-chloro-2-piperidyl)-, dihydrochloride, 2,2',2",2"'-[(4-Piperidinopyrimido[5,4-d-]pyrimidine-2,6-diyl)dinitrilo]tetraethanol, 2-((p-Bromo-alpha-phenylbenzyl)oxy)-N,N-dimethylethylamine Hydrochloride, 2-(2-Pyridyl)ethylidine-1,1-bisphosphonate, 2-(p-Aminobenzenesulfonamido)-5-methylthiadiazole, 2-(p-Aminophenyl)-2-ethylglutarimide, 2-(p-Bromo-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine Maleate, 2-(p-Chloro-alpha-(2-(dimethylamino)ethoxy)benzyl)pyridine Bimaleate, 2-(Propylamino)-o-propionotoluidide Hydrochloride, 2-Phenazinamine, 3,5-dihydro-N,5-bis(4-chlorophenyl)-3-((1-methylethyl)imino)-, 2-Phenyl-1,3-propanediol Dicarbamate, 2-Phenylethyl 3-(3,4-dihydroxyphenyl)-2-propenoate, 2-Phenylethylhydrazine Hydrogen Sulphate, 2-Piperidineacetic Acid, Alpha-phenyl-, Methyl Ester, Hydrochloride, (alphaR,2R)-, 2-piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate Hydrochloride, 2-Propanol-1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy) Hydrochloride, 2-Propanone, 2-Propenamide, 2-Propenenitrile, 2-Propylpentanoic Acid, 2-Propylpentanoic Acid Sodium Salt, 2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic Acid, 2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine, 2-[p-(2-Chloro-1,2-diphenylvinyl)phenoxy]triethylamine Citrate, 20p, 20pd, 20pm, 21p, 21pd, 21pm, 22p, 22pd, 22pm, 239PU, 23p, 23pd, 23pm, 24p, 24pd, 24pm, 25p, 25pd, 25pm, 26p, 26pd, 26pm, 27p, 27pd, 27pm, 28p, 28pd, 28pm, 29p, 29pd, 29pm, 2p, 2pd, 2pm, 2PP2A, 3 Prime Repair Exonuclease 1, 3,3',4',5,7-Pentahydroxyflavone, 3,5-Pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylsulfinyl)ethyl)-, 3,5-Pyridinedicarboxylic Acid, 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-2,6-dimethyl-, Methyl 1-methylethyl Ester, 3-(p-(bis(2-chloroethyl)amino)phenyl)-L-Alanine, Hydrochloride, 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one, 3-Phenylacetylamino-2, 6-piperidinedione, 3-Phosphoinositide Dependent Protein Kinase-1, 3-Phosphoinositide Dependent Protein Kinase-1 Gene, 3-Pyridinecarboxamide, 30p, 30pd, 30pm, 31p, 31pd, 31pm, 32p, 32pd, 32pm, 3p, 3p, 3pd, 3pm, 4-(3-(p-Butoxyphenoxy)propyl)morpholine Hydrochloride, 4-Pergamid, 4-Phenylbutyric Acid, 4-Piperidinecarboxylic Acid, 1-(3-cyano-3,3-diphenylpropyl)-4-phenyl-, Monohydrochloride, 4-Piperidinecarboxylic Acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, Monohydrochloride,(-)-(1(cis)3alpha,4beta)-, 4p, 4pd, 4pm, 5p, 5p Deletion Syndrome, 5pd, 5pm, 6 phosphofructokinase, 6-Propyl-2-thiouracil, 6p, 6pd, 6pm, 7p, 7pd, 7pm, 8p, 8p, 8p22, 8pd, 8pm, 9-(2-phophonylmethoxyethyl)adenine, 9p, 9pd, 9pm, P, p aminobenzoate, p aminohippurate, P-638… (-)-Quinine, 11q, 11q23, 14q, 18q, 1q, 2,4-Quinazolinediamine, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-, 4q Chemokine, 5q, 5q- Syndrome, 5q31, 6-Quinoxalinamine, 5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-,(2R,3R)-2,3-dihydroxybutanedioate(1:1), 7q, 7q31, Q, Q fever, Q fever, Q-Beta Replicase or probe amplification category method, Q01, Q01, Q26, Q27, Q28, Q29, Q30, Q02, Q03, Q04, Q05, Q06, Q07, Q08, Q09, Q11, Q13, Q15, Q16, Q17, Q21, Q22, Q23,Q24, Q25, QA, QA, QA number, Qagan Tayagungin Tribe of Sand Point Village, QALY, Qawalangin Tribe of Unalaska, QBP - Personnel Information by Segment Query, QBP - Query by parameter requesting an RDY display response, QBP - Query by parameter requesting an RSP segment pattern response, QBP - Query by parameter requesting an RTB - tabular response, QBP _ Allocate identifiers, QBP _ Find candidates, QBP _ Get corresponding identifiers, QBP _ Get person demographics, QC Error, QC Warning, QCN/ACK _ Cancel query/acknowledge message, QND/VBL, QOC, QOL, QRF - Waveform result, response to query, QRY - PC/ goal query, QRY - PC/ pathway (goal-oriented) query, QRY - PC/ pathway (problem-oriented) query, QRY - PC/ problem query, QRY - Query for results of observation, QRY/ADR - Patient query, QRY/DOC - Document query, QRY/DSP - Generate bill and A/R statements, QRY/DSR - Query sent for immediate response, QRY/DSR Display-oriented results, query/unsol. update (for backward compatibility only) (Replaced by Q05), QRY/QCK - Query sent for deferred response, QS, Qs, QS, QS21, QS21/RAS peptide cancer vaccine, QS21/TF(c)-KLH, QS21/Tn(c)-KLH, QS21/Tyrosinase Peptide, QSB _ Create subscription, QSX/ACK _ Cancel subscription/acknowledge message, QTL, Quaalude, Quad-FERM+, Quadramet, QUADRANT RESECT BREAST, Quadrant, Left Lower, Quadrant, Left Upper, Quadrant, Right Lower, Quadrant, Right Upper, Quadratus Lumborum, QUADRICEPSPLASTY, Quadrigeminal Artery, Quadrigeminal Cistern, quadriplegia, Quadriplegia and quadriparesis, QUADRUPLET PREG-ANTEPART, QUADRUPLET PREG-DELIVER, Quadruplet pregnancy, Quadruplet pregnancy with fetal loss and retention of one or more fetus(es), Quadruplet pregnancy with fetal loss and retention of one or more fetus(es), antepartum condition or complication, Quadruplet pregnancy with fetal loss and retention of one or more fetus(es), delivered, with or without mention of antepartum condition, Quadruplet pregnancy with fetal loss and retention of one or more fetus(es), unspecified as to episode of care or not applicable, Quadruplet pregnancy, unspecified as to episode of care, quail, quailpox virus, qualified entity, QualifiedRoleType, Qualitative Evaluation, Qualitative platelet defects, Quality, Quality Control, Quality Control, Quality Control, Quality Control For Micro, Quality Management, Quality of Health Care Assessment, Quality of Life Assessment, Quantitative microbial culture, cup, Quantitative microbial culture, droplet, Quantitative microbial culture, filter paper, Quantitative microbial culture, pad culture, Quantitative microbial culture, pour plate, Quantitative microbial culture, surface streak, Quantity, Quantity limited request, Quantity method, Quantity not sufficient, quantum chemistry, Quantum Dot, Quapaw Tribe of Indians, Oklahoma, quart, QUARTAN MALARIA, Quartz Valley Indian Community of the Quartz Valle, Quassinoid Agent, quaternary ammonium compound, quebrachamine, Quechan Tribe of the Fort Yuma Indian Reservation,, QUEENSLAND TICK TYPHUS, Query by parameter, Query for previous events, Query for results of observation, Query for vaccination record, Query input parameter list, Query name, Query priority, Query response for order status, Query Response Status, Query results level, Query selection criteria, Query, original mode, Query/response format code, QueryParameterError, QueryParameterValue, QueryPriority, QueryQuantityUnit, QueryResponse, QueryStatusCode, Question of pregnancy (excl W02), Questionable covered service, questionnaire, QUETIAPINE, queue, Quileute, Quileute Tribe of the Quileute Reservation, Washin, quin 2, quinacrine, Quinacrine fluorescent stain, Quinaglute, QUINAPRIL, Quinapril Hydrochloride, Quinault, Quinault Tribe of the Quinault Reservation, Washin, quinazoline, QUINESTROL, QUINETHAZONE, quinolinate, quinoline analog, quinoline blue, quinolizine, quinolone, quinoxaline, quinpirole, quinuclidine, QUIPAZINE, QUIPAZINE MALEATE, quisqualate, quisqualate receptor, Quixin, Qvar, QVR _ Query for previous events… (-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic Acid, Hydrochloride, (1R,2R)-2-(2-Carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-veratrylisoquinolinium Benzenesulfonate, Pentamethylene Ester, (1R,2S)-(1,2-Epoxypropyl)phosphonic Acid, compound with 2-Amino-2-(hydroxymethyl)-1,3-propanediol(1:1), (1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,2, (1R-(1alpha(1R*,2E,4E),3abeta,4E(1R*,3S*,5Z),7aalpha))-5-((1-(6-Ethyl-6-hydroxy-1-methyl-2,4-octadienyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-1,3-cyclohexanediol, (2'R,3S,3'R,3'aS,6'S,6aS,6bS,7'aR,11aS,11bR)-1,2,3,3'a,4,4',5',6,6',6a,6b,7,7',7'a,8,11,11a,11b-Octadecahydro-3',6',10,11b-tetramethylspiro[9H-benzo[a]fluorene-9,2'(3'H)-furo[3,2-b, (2"R)-4'-O-Tetrahydropyranyladriamycin, (2R,3R)-(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol, 2,3-Dihydoxybutanedioate Monohydrate (1:1) (Salt), (2R,3R,4S)-4-(1,3-Benzodioxo-5-yl)-1-(2-(dibutylamino)-2-oxoethyl)-2-(4-methoxyphenyl)-3-pyrrolidinecarboxylic Acid, (2R,3S)-N-Hydroxy-N-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide, (2R,3S,4R,5R,8R,10R,11R,12S,13S,14R)-13-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy]-2-ethyl-3,4,10-trihydroxy-3,5,6,8,10,12,14-heptamethyl-11-[(3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopentad, (2R,3S,4S,5E,7S,8S,9R)-2,9- Dihydroxy-3,4;7,8-diepoxy-undeca-5,10-diene, (3R,3'R,6'R)-beta,epsilon-Carotene-3,3'-diol, (3R,4S,5S,6R)-5-Methoxy-4- [(2R,3R)-2-methyl-3-(3-methyl-2-butenyl) -oxiranyl]-1-oxaspiro [2,5] oct-6-yl(chloroacetyl) Carbamate, (3R,5aS,6S,10aR)-2,3,5a,6-Tetrahydro-6-hydroxy-3-(hydroxymethyl)-2-methyl-10H-3,10a-epidithiopyrazino[1,2-a]indole-1,4-dione, (3R,5S,6E)-(+/-)-7-(3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl)-3,5-dihydroxy-6-heptenoic Acid, (6R)-DDATHF, (6R, 7S)-7-[(R)-2-Amino-2-phenylacetamido]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid, Monohydrate, (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, (6R,7R)-3-(((5-Methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(2-(1H-tetrazol-1-yl)acetamido)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (6R,7R)-7-(((2R)-Amino(4-hydroxyphenyl)acetyl)amino)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (6R,7R)-7-((R)-2-Amino-2-(1,4-cyclohexadien-1-yl)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (6R,7R)-7-(R)-Mandelamido-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-carboxylic Acid, (6R,7R,8R,9S,10R,13S,14S,15S,16S,17S)-1,3',4',6,6a,7,8,9,10,11,12,13,14,15,15a,16-Hexadecahydro-10,13-dimethylspiro-(17H-dicyclopropa(6,7:15,16)cyclopenta(a)phenanthrene-17,2'(5'H)-furan)-3,5'(2H)-dione, (6R-trans)-3-(((5-methyl-1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-7-(((1H-tetrazol-1-yl)acetyl)amino)-5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, Sodium Salt, (6R-trans)-7-(((2-(Aminomethyl)phenyl)acetyl)amino)-3-(((1-(carboxymethyl)-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, (R)-(4-Oxido-10-oxo-7-palmitoyl-3,5,9-trioxa-4-phosphapentacosyl)trimethylammonium 4-Oxide, (R)-1-Methyl-4-(1-methylethenyl)cyclohexene, (R)-2-Fluoro-alpha-methyl[1,1'-biphenyl]-4-acetic Acid, (R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7, 8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol, (R)-4-(3,4-Dihydro-8,8-dimethyl-2H,8H-benzo(1,2-b:3,4-b')dipyran-3-yl)-1,3-benzenediol, (R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide, (R)-6'-Hydroxy-3'-(hydroxymethyl)-2',4',6'-trimethylspiro(cyclopropane-1,5'(5H)-inden)-7'(6'H)-one, (R)-N-[(5-chloro-3,4-dihydro-8-hydroxy-3-methyl-1-oxo-1H-2-benzopyran-7-yl)carbonyl]-L-phenylalanine, (R,S)-N-[3-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino] propyl]tetrahydro-2-furancarboxamide Hydrochloride, (RS)-11beta,16alpha,17,21,-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal w/ butyraldehyde, *Ranges, *Ratios, *Reciprocal Relative Time, *Relative, *Relative Density, *Relative Mass Concentration, *Relative Substance Concentration, *Relative Time, 186Re-Etidronate, 2-Ring Heterocyclic Compound, 224Ra, 3-[[(R)-1-Methyl-2-pyrrolidinyl]methyl]-5-[2-(phenylsulfonyl)ethyl]indole, Monohydrobromide, 3R,4R,5E,10E,12E,14S,26R,26aS)-26-((2-(Diethylamino)ethyl)sulfonyl)-8,9,14,15,24,25,26,26a-octahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 3RD BRN W LOSS HAND-MULT, 3RD BRN W LOSS-ABDOM WLL, 3RD BRN W LOSS-BK OF HND, 3RD BRN W LOSS-CHEST WLL, 3RD BRN W LOSS-FNGR/THMB, 3RD BRN W LOSS-GENITALIA, 3RD BRN W LOSS-HAND NOS, 3RD BRN W LOSS-HEAD MULT, 3RD BRN W LOSS-MULT FNGR, 3RD BRN W LOSS-MULT SITE, 3RD BRN W LOSS-TRUNK NEC, 3RD BRN W LOSS-TRUNK NOS, 3RD BRN W LOSS-UPPER ARM, 3RD BURN W LOSS ARM-MULT, 3RD BURN W LOSS-ARM NOS, 3RD BURN W LOSS-AXILLA, 3RD BURN W LOSS-BREAST, 3RD BURN W LOSS-ELBOW, 3RD BURN W LOSS-FACE NEC, 3RD BURN W LOSS-FINGER, 3RD BURN W LOSS-FOREARM, 3RD BURN W LOSS-HEAD NOS, 3RD BURN W LOSS-PALM, 3RD BURN W LOSS-SCAPULA, 3RD BURN W LOSS-SHOULDER, 3RD BURN W LOSS-SITE NOS, 3RD BURN W LOSS-THUMB, 3RD BURN W LOSS-WRIST, 3RD DEG BRN W LOSS-SCALP, 3RD DEG BURN ABDOMN WALL, 3RD DEG BURN ANKLE, 3RD DEG BURN ARM NOS, 3RD DEG BURN ARM-MULT, 3RD DEG BURN AXILLA, 3RD DEG BURN BACK, 3RD DEG BURN BREAST, 3RD DEG BURN CHEST WALL, 3RD DEG BURN CHIN, 3RD DEG BURN EAR, 3RD DEG BURN ELBOW, 3RD DEG BURN EYE, 3RD DEG BURN FACE NEC, 3RD DEG BURN FINGER, 3RD DEG BURN FOOT, 3RD DEG BURN FOREARM, 3RD DEG BURN GENITALIA, 3RD DEG BURN HAND NOS, 3RD DEG BURN HAND-MULT, 3RD DEG BURN HEAD NOS, 3RD DEG BURN HEAD-MULT, 3RD DEG BURN KNEE, 3RD DEG BURN LEG NOS, 3RD DEG BURN LEG-MULT, 3RD DEG BURN LIP, 3RD DEG BURN LOW LEG, 3RD DEG BURN MULT FINGER, 3RD DEG BURN MULT SITE, 3RD DEG BURN NECK, 3RD DEG BURN NOSE, 3RD DEG BURN PALM, 3RD DEG BURN SCALP, 3RD DEG BURN SCAPULA, 3RD DEG BURN SHOULDER, 3RD DEG BURN THIGH, 3RD DEG BURN THUMB, 3RD DEG BURN TOE, 3RD DEG BURN TRUNK NEC, 3RD DEG BURN TRUNK NOS, 3RD DEG BURN UPPER ARM, 3RD DEG BURN W LOSS-BACK, 3RD DEG BURN W LOSS-CHIN, 3RD DEG BURN W LOSS-EAR, 3RD DEG BURN W LOSS-EYE, 3RD DEG BURN W LOSS-LIP, 3RD DEG BURN W LOSS-NECK, 3RD DEG BURN W LOSS-NOSE, 3RD DEG BURN WRIST, 3RD DEGREE BURN NOS, 3RD DEGREE SUNBURN, 3rd Operative, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one, 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine, Fumarate, R, r, R 1625, R 33,812, R 75251, R 83 842, R 837, R 848, R factor, R pipiens, R(+)XK469, R-41400, R-41468, r-BDNF, R.N., R01, R01 Mechanism, R02, R03 grant (Fogarty International Center), R04, R07, R08, R09, R10 grant, R115777, R13 grant, R18 grant, R21, R22, R23, R24, R30, R31, R32, R41 grant, R42 grant, R43 grant, R44 grant, R440, R49 grant, Ra, RA-233, RAB8A, rabbit fibroma virus, rabbit kidney vaculolating virus, rabbit papilloma, Rabeprazole, RABIES VACCINATION, rabies virus, rabies, intradermal injection, Rabson Mendenhall syndrome, raccoon, raccoon parvovirus, raccoonpox virus, race, Race, racemization, racial difference, racial discrimination, racial/ethnic difference, Racing, Racing, racism, raclopride, RAD, RAD, RAD 001, RAD DISSEC AXILLARY NODE, RAD DISSEC PERIAORT NODE… (+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione, (+)-(S)-4,4'-(1-Methyl-1,2-ethanediyl)di(2,6-piperazinedione), (+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole, (+)-Simalikalactone D, (+/-)-Sulforaphane, (-) Strand ssRNA Virus, (-)-Salbutamol Hydrochloride, (15S)-15-Methylprostaglandin F(sub 2alpha) Tromethamine, (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-6,11-dioxo-1-naphthacenyl-3-amino-2,3,6-trideoxy-alpha-L-hexopyranoside, (1S,3S,7S,10R,11S,12S,16R)-7,11-Dihydroxy-8,8,10,12,16-pentamethyl-3-[(1E)-1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-17-oxa-4-azabicyclo[14.1.0]heptadecane-5,9-dione, (2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl Ester, (2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic Acid, (2S,3S)-3,4-Dimethyl-2-phenylmorpholine L-(+)-tartrate(1:1), (2S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,10,12-tetrahydroxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside, (2S,5R,6R)-6-((R)-2-Amino-2-phenylacetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, (2S-cis)-Benzoic Acid[1-[4-[3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3-naphthacenyl]ethylidene]hydrazide, (3S)-N-Hydroxy-2,2-dimethyl-4-{{4-(4-piridinyloxy)phenyl}sulfonyl}-3-thiomorpholinecarboxamide, (3S,3'S)-3,3'-Dihydroxy-beta,beta-carotene-4,4'-dione, (4S,4aR,5S,5aR,12aS)-7-Chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide Mono(5-sulfosalicylate)(Salt), (4S,4aR,5S,5aR,6S,12aS)-4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxonaphthacene-2-carboxamide, Monohydrochloride, (4S,4aS,5aS,6S,12aS)-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride, (4S-(4R*,7S,8R*,9R*,13Z,16R*(E)))-4,8-Dihydroxy-5,5,7,9,13-pentamethyl-16-(1-methyl-2-(2-methyl-4-thiazolyl)ethenyl)oxacyclohexadec-13-ene-2,6-dione, (8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione, (8S-cis)-10-((3-Amino-2,3,6-trideoxy-beta-L-arabino-hexopyranosyl)oxy-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione Hydrochloride, (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione, (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-tri-hydroxy-1-methoxy-5,12-naphthacenedione Hydrochloride, (8S-cis)-8-Acetyl-10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione, (9S)-6'-Methoxycinchonan-9-ol Sulfate (2:1) (salt), (S)-(-)-Perillyl alcohol, (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline, (S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol, (s)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione, (S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4'
6,7] indolizino[1,2-b] quinoline-3,14-(4H,12H)-dione monohydrochloride, (S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole, (S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole Monohydrochloride, (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide, (S)-alpha-Methylbenzeneethanamine Sulfate, (S)-dihydroorotate:oxygen oxidoreductase, (S)-N,N'-bis(2-Hydroxy-1-(hydroxymethyl)ethyl)-2,4,6-triiodo-5-lactamidoisophthalamide, (S)-N,N,alpha-Trimethylphenethylamine, (S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide, (S)-n1-[3-[(1-phenylethyl)amino]propyl]bleomycinamide, (S)-Pyrrolidinecarbodithioic Acid, (S-(R*,R*))-1,2,3,4-butanetetrol,1,4-dimethanesulfonate, (SP-4-2)-Diamminedichloroplatinum, (SP-4-2)-diammine[1,1-cyclobutanedicarboxylato(2--)-O,O']platinum, *Saturation Fraction, *Substance Amount, *Substance Concentration, *Substance Concentration Increment, *Substance Concentration Ratio, *Substance Content, *Substance Content Rate, *Substance Fraction, *Substance Rate, *Substance Ratio, *Susceptibility, 1, 10s, 11s, 12s, 13s, 14-3-3 Sigma, 14s, 153Sm-EDTMP, 15s, 16s, 17s, 18s, 18S Ribosomal RNA, 19s, 1s, 1ST DEG BURN ABDOMN WALL, 1ST DEG BURN ANKLE, 1ST DEG BURN ARM NOS, 1ST DEG BURN ARM-MULT, 1ST DEG BURN AXILLA, 1ST DEG BURN BACK, 1ST DEG BURN BREAST, 1ST DEG BURN CHEST WALL, 1ST DEG BURN CHIN, 1ST DEG BURN EAR, 1ST DEG BURN ELBOW, 1ST DEG BURN EYE, 1ST DEG BURN FACE NEC, 1ST DEG BURN FINGER, 1ST DEG BURN FOOT, 1ST DEG BURN FOREARM, 1ST DEG BURN GENITALIA, 1ST DEG BURN HAND NOS, 1ST DEG BURN HAND-MULT, 1ST DEG BURN HEAD NOS, 1ST DEG BURN HEAD-MULT, 1ST DEG BURN KNEE, 1ST DEG BURN LEG NOS, 1ST DEG BURN LEG-MULT, 1ST DEG BURN LIP, 1ST DEG BURN LOWER LEG, 1ST DEG BURN MULT FINGER, 1ST DEG BURN MULT SITE, 1ST DEG BURN NECK, 1ST DEG BURN NOSE, 1ST DEG BURN PALM, 1ST DEG BURN SCALP, 1ST DEG BURN SCAPULA, 1ST DEG BURN SHOULDER, 1ST DEG BURN THIGH, 1ST DEG BURN THUMB, 1ST DEG BURN TOE, 1ST DEG BURN TRUNK NEC, 1ST DEG BURN TRUNK NOS, 1ST DEG BURN UPPER ARM, 1ST DEG BURN WRIST, 1ST DEGREE BURN NOS, 1st non-Operative, 2, 20s, 20S Catalytic Proteasome, 21s, 22s, 23s, 24s, 254-S, 25s, 26s, 26S ATP-Dependent Protease, 26S Proteasome Regulatory Subunit p28, 27s, 28s, 28S Ribosomal RNA, 29s, 2s, 3, 3 Self-Sustaining Sequence Replication, 30s, 31s, 32s, 3s, 4, 4,4'-Sulfonylbis[benzenamine], 40S Ribosomal Protein S19, 40s Ribosomal Protein S27, 40S Ribosomal Protein S3, 4s, 5s, 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoic Acid]cyclosporin D, 60S Ribosomal pProtein L19, 60S Ribosomal Protein L10, 60S Ribosomal Protein L13, 60S Ribosomal Protein L7a, 60S Ribosomal Protein L8, 6s, 7(S)-Chloro-7-deoxylincomycin 2-phosphate, 7s, 8s, 90Sr, 9s, 9S-6'-Methoxy-cinchonan-9-ol, Mono-D-gluconate(salt), S, s, S 10036, S 28463, S antigen, S element, S nucleosidylaminoacid, S Phase, S-16257, S-2-Propenyl-l-cysteine, S-3304, S-A Node, S-Adenosyl-l-methionine 1,4-Butanedisulfonate, S-Allylcysteine, S. aureus, S. cerevisiae, S01, S02, S03, S04, S05, S06, S07, S08, S09, S10, S11, S03 grant, S06 grant, S07 grant, S1, S1 Vertebra, S10 grant, S100 Calcium Binding Protein, S100 Calcium Binding Protein A11 (Calgizzarin) Gene, S100 Calcium Binding Protein A12 (Calgranulin C) Gene, S100 Calcium Binding Protein A8 (Calgranulin A) Gene, S100 Calcium Binding Protein A9 (Calgranulin B) Gene, S100 Calcium Binding Protein P, S100 Calcium Binding Protein P Gene, S100 Calcium-Binding Protein A2 Gene, S100 Family Gene, S11 grant, S12, S13, S14, S15, S16, S17, S18, S19, S20, S21, S22, S23, S24, S26, S14 grant, S15 grant, S2 Vertebra, S25, S3 Gallop, S3 Vertebra, S35 isotope, S4 Vertebra… (-)-Thalidomide, (201-Tl) Thallous Chloride, *Temperature, *Temperature Difference, *Temperature Increment, *Threshold Mass Concentration, *Threshold Substance Concentration, *Time (e.g. seconds), *Time Difference, *Time Ratio, *Time Stamp — Date and Time, *Type, 1, 1,1'-(2,2,2-Trichloroethylidene)-bis[4-chlorobenzene], 1,1'-Thiobis(2-chloroethane), 1,1,1-Trifluoro-2-bromo-2-chloroethane, 1,1,2,2-Tetrachloroethylene, 1,1,2,2-Tetrafluoroethylene, 1,2,3,4-Tetrahydro-1,1,4,4-tetramethyl-6-[(1E)-1-methyl-2-phenylethenyl]naphthalene, 1,2,3,4-Tetrahydro-1-(3,4,5-trimethoxybenzyl)-6,7-isoquinolinediol, 1,2,3,4-tetrahydro-9-acridinamine Monohydrochloride Monohydrate, 1,2,3-Trichloropropane, 1,2,4-triazine-3,5(2H,4H)-dione, 2-beta-D-ribofuranosyl, 1,2,4-Triazolo(4,3-a)pyridin-3(2H)-one, 2-(3-(4-(3-chlorophenyl)-1-piperazinyl)propyl)-, Monohydrochloride, 1,2,4-Triazolo(4,3-a)pyridine, 5,6,7,8-tetrahydro-3-(2-(4-(2-methylphenyl)-1-piperazinyl)ethyl)-, monohydrochloride, 1,2,4-triglycidylurazol, 1,3, 4-Thiadiazol-2-amine (9CI), 1,3, 5-Triazin-2(1H)-one, 4-amino-1-.beta.-D- arabinofuranosyl- (9CI), 1,3,4,9-Tetrahydro-1,8-diethylpyrano(3,4-b)indole-1-acetic Acid, 1,3,5-triazin-2(1H)-one, 4-amino-3, 6-dihydro-1-beta-D-ribofuranosyl monohydrochloride, 1,3,5-Triazine-2,4,6-triamine, N,N,N',N', N''-pentamethyl-, monohydrochloride (9CI), 1,3,7-trimethylxanthine, 1,3,8-Trihydroxy-6-methylanthraquinone, 1,4,5,8-Tetraamino Anthraquinone, 1,4,5,8-Tetroxyantraquinone, 1,4,7,10-Tetraazacyclododecane-1,4,7,10-Tetramethylene-Phosphonic Acid, 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 2, 2',3,4,4'-Tetrahydroxy-chalcone, 2,2', 2''-Trichlorotriethylamine, 2,3,4,5-tetrahydroxy-1,6- dioxido-hexane-1,6-dione, Calcium, 2,3,7,8-Tetrachlorodibenzo[b,e][1,4]dioxin, 2,3,7,8-Tetrahydroxy[1]benzopyrano[5,4,3-cde][1]-benzopyran-5,10-dione, 2,4 thiazolidinedione, 2,4,5 T, 2,4,5 trichlorophenoxyacetate, 2,4,5-Trihydroxyphenethylamine, 2,4,6-Trichlorophenol, 2,4,6-Tris(dimethylamino)-s-triazine, 2,6,10,14-Tetramethylpentadecane, 2-(2,3,5-Tri-O-acetyl-beta-D-ribofuranosyl)-as-triazine-3,5(2H,4H)-dione, 2-Thiophenecarboxylic Acid, 4-Methyl-3-((1-oxo-2-(propylamino)propyl)amino)-, Methyl Ester, Monohydrochloride, 2-Thiourea, 2.7.1.112, 20, 21, 21-Tungsto-9-antimonate, 22, 23, 24, 25, 26, 27, 28, 29, 3, 3,3',5-triiodo-L-thyronine, 3,4,3',5'-Tetrahydroxy-trans-stilbene, 3,4,4'-Trichlorodiphenylurea, 3,4,5-Trihydroxybenzoic Acid, 3,7,12,17-Tetramethyl-8,13-divinyl-2,18-porphinedipropionic Acid, 3-Tritylthio-L-Alanine, 30, 31, 32, 3T3 cell, 3TC/d4T/IDV, 4, 4',5, 7-Trihydroxyisoflavone, 4',5,7-Trihydroxy-6-methoxyisoflavone, 4,5-Trihydroxybenzylidene malononitrile, 4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile, 4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile Monohydrochloride, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-, 4,4-dioxide, Sodium Salt,(2S-cis)-, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-,(2S-(2alpha,5alpha,6beta))-, Monosodium Salt, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-, Monopotassium Salt, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-(((1-aminocyclohexyl)carbonyl)amino)-3,3-dimethyl-7-oxo-,(2S-(2alpha,5alpha,6beta))-, 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic Acid, 6-((2,6-dimethoxybenzoyl)amino)-3,3-dimethyl-7-oxo-, Monosodium Salt, Monohydrate,(2S-(2alpha,5alpha,6beta))-, 4-Thiazolidine Carboxylic Acid, 4-Thiazolidinecarboxamide, N-(1,1-dimethylethyl)-3- [2-hydroxy-3-[[2-[[(5-isoquinolinyloxy)acetyl]amino]-3- (methylthio)-1-oxopropyl]amino]-1-oxo-4-phenylbutyl]-,[4R-[3[2S*, 3S*(R*)],4R*]], 5, 5'-tct ccc agc gtg cgc cat, 5,10,15,20-Tetra-(m-hydroxyphenyl)chlorin, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, Monosodium Salt(6R-(6alpha,7beta(Z)))-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2,3-dihydro-2-imino-4-thiazolyl)(methoxyimino)acetyl)amino)-8-oxomonosodium Salt,(6R-(6alpha,7beta(Z)))-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1Z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-,2,2-dimethyl-1-oxopropoxy)methyl Ester,(6R,7R)-, 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((4-(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl)carbonyl)amino)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, Disodium Salt,(6R-(6alpha,7alpha))-, 6, 6 thiopurine riboside, 7, 8, 9, C (_cum_), T, T, T, T 1551, T antigen, T cadherin, T Cell, T Cell Receptor Signaling Pathway, T dynamin, T lymphocyte depletion therapy, T lymphocyte marker, T(1)-T(6) level spinal cord injury, unspecified, T(1)-T(6) level with other specified spinal cord injury, T(7)-T(12) level spinal cord injury, unspecified, T(7)-T(12) level with other specified spinal cord injury, T-1220, T-Cell Activation, T-Cell and NK-Cell Neoplasm, T-cell depletion, T-Cell Immunodeficiency, T-Cell Leukemia Translocation Altered Gene, T-Cell Leukemia Translocation Altered Gene Product, T-Cell Leukemia, Homeobox 1 Gene, T-Cell Leukemia/Lymphoma 1B Gene, T-Cell Lymphoma Invasion and Metastasis 1 Gene, T-Cell Proliferation, T-Cell Proliferation of Uncertain Malignant Potential, T-Cell Prolymphocytic Leukemia, Cerebriform Cell Variant, T-Cell Prolymphocytic Leukemia, Small Cell Variant, T-Cell Receptor Alpha, T-Cell Receptor Beta, T-Cell Receptor Delta, T-Cell Receptor Gamma, T-Cell Receptor Gene, T-Cell Receptor Interacting Molecule, T-Cell Receptor, Alpha-Beta, T-Cell Receptor, Gamma-Delta, T-Cell Rich/Histiocyte-Rich Large B-Cell Lymphoma, t-Test, T-Zone Lymphoma, T0, T01, T03, T05, T07, T09, T11, T02, T04, T06, T08, T10, T1, T1 Vertebra, T10 Vertebra, T11 Vertebra, T12, T12 Vertebra, T138067, T138067 Sodium, T1a, T1b, T1c, T2, T2 toxin, T2 Vertebra, T2a, T2b, T2c, T3, T3 Vertebra, T3a, T3b, T3c, T4, T4 Vertebra, T4a, T4b, T4c, T4d, T5 Vertebra, T6 Vertebra, T7 Vertebra, T8 Vertebra, T9 Vertebra, T900607, Ta element, TAB, TAB DISP, tabernanthine, Tabes dorsalis, Table, Table Bluff Reservation - Wiyot Tribe, California, Table Mountain Rancheria of California, Table Rule Style, Table value not found… (+)-UCN-01, /uL, 1592U89, 256U87, 3' Untranslated Region, 5' Untranslated Region, 506U78, 87U6, U 10071, U 10858, U 15167, U 9889, U element, U grant, U-0126, U-101440E, U-11,000A, U-22,550, U-27,182, U-33, 624A, U-42126, U-73,975, U-77779, U-80244, U-Gencin, U/kg, U01, U02, U03, U04, U05, U06, U07, U08, U09, U10 grant, U10, U11, U12, U13, U13 grant, U18 grant, U42 grant, U43 grant, U44 grant, UA, UB value code and amount, UBB, UBC, UBD, UBE2D2, ubiquilin, Ubiquinone 10, Ubiquinone Biosynthesis, ubiquinylation, ubiquitin, ubiquitin activating enzyme, Ubiquitin C-Terminal Hydrolase, ubiquitin conjugating enzyme, Ubiquitin Ligase Component Gene, Ubiquitin Protein Ligase, Ubiquitin Specific Protease 6 (Tre-2 Oncogene) Gene, Ubiquitin Specific Protease 8 Gene, UC38, UC7 grant, UCB 3983, UCDS, UCS Transformation Format, 16-bit form, UCS Transformation Format, 32-bit form, UCS Transformation Format, 8-bit form, UCUM, udder, UDM/ACK - Unsolicited display update message, UDP, UDP galactose 4 epimerase, UDP Glycosyltransferase 1 Family, Polypeptide A1 Gene, UDP-4, UDPG, UES, UG, ug/g, Ugashik Village, ugent notification contact, UL-FS49, ULC ESOPHAGUS W/O BLEED, ulcer, Ulcer, Ulcer, ULCER ESOPHAGUS W BLEED, ulcer inhibitor, ULCER OF ANKLE, ULCER OF CALF, ULCER OF HEEL & MIDFOOT, ULCER OF LOWER LIMB NOS, Ulcer of lower limbs, except decubitus ulcer, Ulcer of other part of foot, Ulcer of other part of lower limb, ULCER OF THIGH, Ulcer, Decubitus, Ulcerated Oral Leukoplakia, ULCERATION OF INTESTINE, Ulceration of vulva, Ulceration of vulva in diseases classified elsewhere, Ulcerative (chronic) enterocolitis, Ulcerative (chronic) ileocolitis, Ulcerative (chronic) proctitis, Ulcerative (chronic) proctosigmoiditis, ULCERATIVE BLEPHARITIS, ulcerative disease rhabdovirus, Ulcerative Stomatitis, ULCEROGLANDUL TULAREMIA, Ulna, Ulnar Artery, Ulnar Artery Branch, Ulnar Nerve, Ultandren, ultimobranchial body, Ultra frozen, Ultracaine, ultracentrifugation, Ultradol, ultrafiltration, Ultrafiltration, ULTRASON FRAGMENT-STONE, ultrasonic angiocardiography, ultrasound, ultrasound angioplasty, ultrasound biological effect, ultrasound blood flow measurement, ultrasound echoencephalography, ultrasound echooculography, ultrasound microscopy, ultrasound respiratory airflow measurement, ultrasound spectrometry, ULTRASOUND STUDY OF EYE, ultraviolet spectrometry, Umbilical Artery, Umbilical Blood, Umbilical blood, Umbilical blood, umbilical cord, Umbilical cord complications during labor and delivery, Umbilical Fissure, UMBILICAL HERNIA, UMBILICAL HERNIA W GANGR, UMBILICAL HERNIA W OBSTR, Umbilical Hernia with Obstruction without mention of Gangrene, Umbilical Region, Umbilical Vein, UMBILICAL VEIN CATH, Umkumiute Native Village, UML-491, UMP, Una virus, Unable to accept order/service, Unable to cancel, Unable to change, Unable to discontinue, Unable to put on hold, Unable to refill, Unable to release, Unable to replace, UNARMED FIGHT OR BRAWL, UNATTENDED DEATH, Unavailability of other medical facilities for care, Unavailable for patient care, UNC-13 Homolog B (C. Elegans) Gene, Uncertain, Uncertain Narrative Concept Descriptor, Uncertain Probabilistic Concept Descriptor, Uncertain Probabilistic Interval Of Physical Quant, Uncertain Value Narrative, Uncertain Value Probabilistic, UNCHANGED *, uncinate epilepsy, Uncinate Pancreas, Unclassified Renal Cell Carcinoma, uncle, Uncomplicated hypertension, Unconditional, Unconfirmed, uncontrollable child syndrome, Uncontrolled, uncontrolled study, unconventional medicine, unconventional slow virus disease, uncus, Undergraduate, undergraduate nursing education, Underline Font, Undersea and Hyperbaric Medicine, undersocialized aggressive child behavior, Undersocialized conduct disorder, aggressive type, Undersocialized conduct disorder, aggressive type, mild degree, Undersocialized conduct disorder, aggressive type, moderate degree, Undersocialized conduct disorder, aggressive type, severe degree, Undersocialized conduct disorder, aggressive type, unspecified degree, Undersocialized conduct disorder, unaggressive type, Undersocialized conduct disorder, unaggressive type, mild degree, Undersocialized conduct disorder, unaggressive type, moderate degree, Undersocialized conduct disorder, unaggressive type, severe degree, Undersocialized conduct disorder, unaggressive type, unspecified degree… (+-)-Verapamil hydrochloride, *Velocity, *Velocity Ratio, *Viscosity, *Volume, *Volume Content, *Volume Fraction, *Volume Rate, *Volume Ratio, V, V (voltage), V element, v erbB, v fes, v fms, v fps, v H ras, v jun, v K ras, v mos, v myc, v src, V-gas, V-Rasha, v-sis Platelet Derived Growth Factor, Beta Polypeptide, v-Yes-1 Yamaguchi Sarcoma Viral Oncogene Homolog 1 Gene, V0, V01, V02, V03, V04, V1, V2, VA, VA, vacation home, Vacation Home Number, Vacation Supply, vaccination, Vaccination against yellow fever, Vaccination not carried out, Vaccination record response, Vaccine, vaccine delivery, vaccine development, vaccine evaluation, vaccine evaluation center, Vaccine Information, Vaccine Therapy, Vaccine-Draining Lymph Node Lymphocyte Therapy, Vaccine-Sensitized Draining Lymph Node Cells, VaccineManufacturer, Vaccines administered (code = CVX)(parenteral, unless oral is noted), VaccineType, vaccinia immune globulin, Vaccinia-MUC-1 Vaccine/Vaccinia-TRICOM Vaccine, Vaccinia-Prostate-Specific Antigen-TRICOM Vaccine, VaccinOvar, Vacuolar, VACUUM EXT DEL W EPISIOT, Vacuum extraction, VAD (ventricular assist device), VAG RECONST W GRFT/PROS, VAG REPAIR INVERS UTERUS, VAG SUSP/FIX W GRFT/PROS, vagina disorder, Vagina hemorrhage, Vagina Verrucous Carcinoma, Vaginal Abscess, VAGINAL BIOPSY, VAGINAL CONST W GRF/PROS, VAGINAL CONSTRUCTION, Vaginal construction and reconstruction, Vaginal Cream, Vaginal Cuff, Vaginal discharge, VAGINAL DOUCHE, Vaginal Endodermal Sinus Neoplasm, VAGINAL ENTEROCELE, vaginal fluid, Vaginal foam with applicator, Vaginal Fornix, Vaginal Gel, Vaginal Gel with Applicator, VAGINAL HEMATOMA, Vaginal Itching, Vaginal Mass, Vaginal Metastatic Adenocarcinoma, Vaginal Non-Neoplastic Disease, VAGINAL PACKING, VAGINAL RECONSTRUCTION, Vaginal Stricture, Vaginal Suppository, VAGINAL SUSPENS & FIXAT, Vaginal Tablet, Vaginal Vault, VaginalRoute, VAGINISMUS, vaginitis, Vaginitis and vulvovaginitis, Vaginitis and vulvovaginitis in diseases classified elsewhere, Vaginitis/vulvitis NOS, VAGINOSCOPY, vagotomy, Vajrayana (Tibetan), valaciclovir, Valacyclovir Hydrochloride, Valencian, VALERIAN, Valganciclovir, Valgus deformities of feet, congenital, Valgus deformity of wrist (acquired), valine, Valium, Vallecula, Valsalva's maneuver, Value, Value code, Value not found in code system, Value range, Value type, Valve, Valve of Vieussens, VAMP, van der Hoeve Halbertsona Waardenburg syndrome, van der Waals force, van der Woude syndrome, vanadate, Vancenase, Vanceril, VANCOMYCIN, vanillylmandelate, Vaniqa, Vanlev, vapor, Vapreotide, Vaqta, Variable, variable region gene, Variants of migraine, Variants of migraine, with intractable migraine, so stated, Variants of migraine, without mention of intractable migraine, VARIATIONS IN HAIR COLOR, VARIC VEIN LEG PREG-UNSP, VARIC VEIN LEG,COMP NEC, VARIC VEIN LEG-DEL W P/P, VARIC VULVA PREG-UNSPEC, Varicella (hemorrhagic) pneumonitis, VARICELLA UNCOMPLICATED, varices, VARICES OF OTHER SITES, Varicola virus, VARICOS LEG ULCER/INFLAM, VARICOSE VEIN LEG-DELIV, Varicose veins of legs, Varicose veins of legs in pregnancy and the puerperium, Varicose veins of vulva and perineum in pregnancy and the puerperium, Varicose veins of vulva and perineum, antepartum, Varicose veins of vulva and perineum, postpartum, Varicose veins of vulva and perineum, with delivery, with mention of postpartum complication, Varicose veins of vulva and perineum, with delivery, with or without mention of antepartum condition, Varies, VARIOLA MAJOR, variola major virus, Varus deformity of wrist (acquired), VAS, vas deferens, vas deferens surgery, Vasa previa complicating labor and delivery, Vasa previa complicating labor and delivery, antepartum, Vasa previa complicating labor and delivery, delivered, vasa vasorum, Vasal, VASC COMP MESENTERIC ART, VASC COMP RENAL ARTERY, VASC DEMENTIA W DELIRIUM, VASC DEMENTIA W DELUSION, VASC DEMENTIA W DEPRESSN, VASC LESION CORD-ANTEPAR, VASC LESION CORD-DELIVER, VASC LESION CORD-UNSPEC, Vascor, vascular, Vascular & Interventional Radiology, VASCULAR ANOM POST EYE, vascular bed, Vascular Breast Neoplasm, Vascular Cell Adhesion Molecule-1 Gene, Vascular Channel Formation, Vascular Collagenous Stroma Formation, VASCULAR COMP VESSEL NEC, vascular compliance, Vascular dementia, uncomplicated, Vascular disorders of iris and ciliary body, Vascular Ectasia, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor C Gene, Vascular Endothelial Growth Factor Trap, vascular endothelioma, Vascular Endothelium… "" w/o Surgery Capability, 0-6 weeks old, 141W94, 3622W94, 51W89, W, W01, W02, WA, Waardenburg anophthalmia syndrome, WAFER, WAGR Syndrome, WAIS (wide area information server), Waist, Waist-Hip Ratio, wait, waitContinuedQueryResponse, Wakashan, wakefulness, Waldenstrom's disease, Wales, walk-in, Walk-in clinic, Walker River Paiute Tribe of the Walker River Rese, walking, Wall, Wall of Body of Uterus, Wall of Prostatic Duct, wallaby, Wallal virus, Wallet Card, WALLIS AND FUTUNA, walrus, Wampanoag Tribe of Gay Head (Aquinnah) of Massachu, WAN (wide area network), Wandering Atrial Pacemaker, WAP Four-Disulfide Core Domain 1 Gene, WAP Four-Disulfide Core Domain 2 Gene, Wappo, war, war/peace, warbler, ward, Ward, Ward of court, Ward of the court, WARFARIN POTASSIUM, warm antibody hemolytic anemia, Warning, Warning, Warrant Officers, warranted product, Warrego virus, Wart, Warthin-Starry Staining Method, Warts, WAS, Wash, Wash, Wash, Washed, Washed Packed Cells, Washing, e.g. bronchial washing, Washo, Washoe Tribe of Nevada & California (Carson Colony, wasp, waste disposal, waste treatment, Wasted (product no longer viable), wasting, Watasenia luciferin 2 monooxygenase, Water, Water, WATER, water conservation, water drinking behavior, water electrolyte balance therapy, water environment, water flea, water flow, water microbiology, water mold, water organism, water pollution, water pollution control, water quality, water sampling/testing, water solubility, water solution, water supply, water testing, WATER TRANSPORT ACCIDENTS, water treatment, Water, mineral, and uric acid metabolism drugs causing adverse effects in therapeutic use, Water-Clear Cell Adenocarcinoma, Water-Soluble Vitamin, Waveform source, Wavelength, Waxy Cast Formation, Wb, WD Repeat Domain 22 Gene, weaning, weanling animal, weaponized microorganism, weather, WEBBING OF NECK, Wechsler Intelligence scale, Wedge, Wedge Biopsy, Wedge Biopsy of Liver, Wedge Excision, Wedge Excision of Lung, Wedge osteotomy, WEDGE OSTEOTOMY NEC, Wedge Resection of Tongue, Wednesday, WEE virus, weed pollen, weed pollen allergy, week, Week, week (continuous), week of the year, Weekend Supply, Wegener's granulomatosis, WEIGHT, weight control, weight control agent, Weight gain, Weight loss, Weimaraner, welfare, welfare (mental health), welfare assistance, Well Differentiated Chondrosarcoma, Well Differentiated Fibrosarcoma, Well Differentiated Islet Cell Neoplasm, Well Differentiated Leiomyosarcoma, Well Differentiated Lesion, Well Differentiated Liposarcoma, Well Differentiated Malignant Hemangiopericytoma, Well Differentiated Malignant Neoplasm, Well Differentiated Oligodendroglial Tumor, Well Differentiated Ovarian Sertoli-Leydig Cell Tumor, Well Differentiated Prostate Adenocarcinoma, Wellbutrin, Wellcovorin, Wellferon, Welsh Corgi, Welsh Terrier, Wen, Werdnig Hoffmann paralysis, Werner Syndrome Gene, Werner Syndrome Protein, West Highland White Terrier, West Indian, West New Guinea, West Nile fever, WEST NILE FEVER W/ENCEPH, West Nile Fever with other complications, West Nile Fever with other neurologic manifestation, West Nile virus, West Virginia, Western Blot, WesternApachean, WesternMiwok, WesternMuskogean, WesternNumic, wet scrubber, WF-1360, whale, Wharton's Jelly, What subject filter, Whataroa virus, wheat or gluten, Wheel of Wheelchair, wheelchair, Wheelchair, Wheelchair/stretcher bound, Wheezing, where xxx is some frequency code, Whey Protein, Which date/time qualifier, Which date/time status qualifier, whiplash, Whippet, WHIPPLE'S DISEASE, WHIRLPOOL TREATMENT, WHITE, white adipose tissue, white coat hypertension, white footed mouse, White Matter of the Spinal Cord, White Mountain Apache Tribe of the Fort Apache Res, white muscle disease, White Phosphorus, white rot fungus, White Spot Lesion, WHO, WHO Adverse Reaction Terms… 1.6605402 x 10-24 g, 46XX, 714-X, X Inactivation, X inherited trait, X linked trait, X ray diffraction analysis, X ray emission spectrometry, X ray emission spectroscopy, X ray fluorescent probe, X ray microscopy, X ray spectrometry, X ray spectroscopy, X ray visualization, X-AVI Video, X-Linked Lymphoproliferative Syndrome, X-Linked Severe Combined Immunodeficiency, X-ray Angiography, X-Ray Cross Complementing Group, X-RAY NEC AND NOS, X-ray of female genital organs, X-RAY OF GRAVID UTERUS, X-ray of male genital organs, X-ray of spine, X-ray of urinary system, X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 1 Gene, X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 2 Gene, X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 3 Gene, X-Ray Repair Complementing Defective Repair in Chinese Hamster Cells 4 Gene, X-ray Repair Complementing Defective Repair in Chinese Hamster Cells 5 (Double-Strand-Break Rejoining; Ku Autoantigen, 80kDa) Gene, X-RAY STUDY OF EYE, X-Ray Tube, X.400 email address: Use Only If Telecommunication Use Code Is NET, XAF1, Xalatan, Xaliproden Hydrochloride, Xanax, xanthelasmatosis, xanthene, xanthine, xanthine analog, Xanthine Dehydrogenase Gene, Xanthine Oxidase Inhibitor, Xanthogranulomatous Cholecystitis, Xanthoma, xanthoma tuberosum multiplex, xanthomatous reticuloendotheliosis, Xanthomonas, xanthone, Xanthophylls, Xcytrin, Xe element, Xeneisol, Xenical, xenobiotic, Xenobiotic Metabolism, xenobiotic monooxygenase, xenograft, Xenopus, Xenopus, Xenopus oocyte, Xeroderma, XERODERMA OF EYELID, Xeroderma Pigmentosum Complementation Group A, Xeroderma Pigmentosum Complementation Group A Protein, Xeroderma Pigmentosum Complementation Group B, Xeroderma Pigmentosum Complementation Group D, Xeroderma Pigmentosum Complementation Group F, Xeroderma Pigmentosum Complementation Group G, Xeroderma Pigmentosum, Complementation Group A Gene, xerography, xerotic keratitis, Xibenolol, Xiphen, Xiphisternum, Xipranolol, XML Text, XMLV1PR1, Xolair, XomaZyme, XomaZyme-CD5 Plus, Xopenex, XR5000, XR9576, XY-H65, Xylocaine, Xylocitin, XYLOSE, Xylotox, Xyotax, Xyrem, _X_ times per day at institution-specified times, where X is a numeral 5 or greater.… 0-11 years old, 1 year old, 1-5 years old, 100+ years old, 12-20 years old, 21+ years old, 21-34 years old, 35-64 years old, 6-11 years old, 65+ years old, 85+ years old, 90 Y-B3, 90Y, 90Y-DOTA-Biotin, Y, Y 12278, Y 90 Ibritumomab Tiuxetan, Y 90 Monoclonal Antibody CC49, Y inherited trait, Y protein, Y90 Daclizumab, Y90 MOAB Hu3S193, Yaba monkey tumor virus, YAC, Yakutat Tlingit Tribe, Yankton Sioux Tribe of South Dakota, Yaohushua, Yaqui, YARD, Yatapoxvirus, Yavapai-Apache Nation of the Camp Verde Indian Res, Yavapai-Prescott Tribe of the Yavapai Reservation,, yaws, Yb element, YE, year, year, year (mean Gregorian), year (mean Julian), year (tropical), yearning, yeast, yeast genetics, Yeast Protein, Yeast Protein Complex, yeast ribonuclease, yeast two hybrid interaction screening, YEAST, DRIED, YEATS Domain Containing 4 Gene, YELLOW, yellow algae, yellow fever, yellow fever, yellow fever virus, Yellow Fever Virus Infection, Yen, Yerington Paiute Tribe of the Yerington Colony & C, Yersinia, Yersinia enterocolitica, Yersinia pestis, Yersinia pseudotuberculosis, Yes, Yes, Yes, patient has a living will, Yes, patient has a living will but it is not on file, Yes, patient is a documented donor and documentation is on file, Yes, patient is a documented donor, but documentation is not on file, Yes/no indicator, ylide, YM-08310, YM175, YM598, yocto, yoga, Yokutsan, Yomba Shoshone Tribe of the Yomba Reservation, Nev, Yondelis, Yorkie, yotta, Youth, Ysleta Del Sur Pueblo of Texas, Yttrium Y 90 -DOTATOC, Yttrium Y 90 Glass Microspheres, yttrium Y 90 SMT 487, Yuan Renminbi, Yuchi, Yug Bogdanovac virus, Yugoslavia, Yuki, Yukian, Yuman, Yupiit of Andreafski, Yurok, Yurok Tribe of the Yurok Reservation, California… (1Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic Acid, 4-(Nitrooxy)butyl Ester, (1Z)-5-Fluoro-2-methyl-1-[[4-(methylthio)phenyl]methylene]-1H-indene-3-acetic Acid, (Z)-1-(2-(2,4-Dichlorophenyl)-2-(((2,4-dichlorophenyl)oxy)imino)ethyl)-1H-imidazole Mononitrate, (Z)-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate, (Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine, (Z)-2-[4-(4-Chloro-1,2-diphenyl-1-butenyl)phenoxy]-N,N-dimethylethanamine 2-Hydroxy-1,2,3-propanetricarboxylate (1:1), (Z)-5-fluoro-2-methyl-1-[[4-(methylsulfinyl)phenyl]methylene]-1H-indene-3-acetic acid, (Z)-5-Fluoro-2-methyl-1-[[4-(methylsulfonyl)phenyl]methylene]-1H-indene-3-acetic Acid, (Z,Z)-9,12-Octadecadienoic Acid, 2-[4-[(1Z)-1,2-Diphenyl-1-butenyl]phenoxy]-N-methylethanamine, 7-((4Z)-3-(Aminomethyl)-4-methoxyiminopyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)naphthyridine-3-carboxylic Acid Monomethanesulfonate, Z DNA, Z-DNA Binding Protein, ZA, Zabiciprilat, Zaditen, Zaleplon, ZAMIFENACIN, Zanosar, Zantac, ZAP70, Zaprinast, Zardaverine, Zarnestra, Zarontin, Zaroxolyn, ZBTB17, ZD 1839, ZD-1033, ZD0473, ZD1694, ZD2767, ZD4054, ZD6126, ZDX, zebra finch, Zelandopam, Zemplar, Zemuron, Zen Buddhism, Zeniplatin, Zeolite, zepto, zerit, Zestril, zeta potential, ZETIDOLINE, zetta, Zevalin, ZFP36L2, ZI, Ziac, Ziba-Rx, ZICONOTIDE, Zidometacin, ZIFT, Zinacef, Zinc Chromate, zinc finger, Zinc Finger Protein 217, Zinc Finger Protein 217 Gene, Zinc Sulfide, ZINDOXIFENE, Zinecard, ZIPAN, Zipeprol, Ziprasidone Mesylate, zirconium, Zithromax, ZK 36374, zlib, ZM 252868, zocor, Zofran, Zoledronic Acid, ZOLIMIDINE, Zoloft, ZOLPIDEM, Zolpidem Tartrate, Zomax, ZOMEPIRAC, Zomepirac Sodium, Zometapine, zona drilling, zona pellucida, zona pellucida glycoprotein, zonal electrophoresis, Zoniporide, Zoogloea, Zoology, Zoonotic Infection, ZOOPHILIA, zooplankton, zoosemiotics, Zoroastrianism, Zosuquidar Trihydrochloride, zovirax, zoxazolamine, ZP1, ZP2, Zu, Zucker rat, ZUCLOMIPHENE, ZUCLOPENTHIXOL, Zulex, Zuni, Zuni Tribe of the Zuni Reservation, New Mexico, Zuotin, Zyban, Zygoma, zygomatic arch, ZYGOMATIC HYPERPLASIA, ZYGOMATIC HYPOPLASIA, Zygomaticus Major, Zygomaticus Minor, Zygomycetes, ZYGOMYCOSIS, Zygote, Zyloprim, Zymar, Zymase, zymosan, Zyrtec… … |
home 
Armenian-English 
top